{"subnetworks": [{"diseases": ["PERIPHERAL ARTERIAL DISEASE", "CHRONIC KIDNEY DISEASE", "ALZHEIMERS DISEASE", "NEOPLASM"], "links": [{"source": "ENSG00000008517", "target": "ENSG00000196415", "reverse": "rev-stimulatory"}, {"source": "ENSG00000010438", "target": "ENSG00000197249"}, {"source": "ENSG00000021355", "target": "ENSG00000196415"}, {"source": "ENSG00000021355", "target": "ENSG00000197561"}, {"source": "ENSG00000049540", "target": "ENSG00000196415"}, {"source": "ENSG00000049540", "target": "ENSG00000197561"}, {"source": "ENSG00000099953", "type": "directed", "target": "ENSG00000197249"}, {"source": "ENSG00000100448", "type": "directed", "target": "ENSG00000137033"}, {"source": "ENSG00000100448", "type": "stimulatory", "target": "ENSG00000164251"}, {"source": "ENSG00000106366", "target": "ENSG00000149968", "reverse": "rev-stimulatory"}, {"source": "ENSG00000106366", "type": "inhibitory", "target": "ENSG00000197561", "reverse": "rev-stimulatory"}, {"source": "ENSG00000124107", "type": "inhibitory", "target": "ENSG00000197561", "reverse": "rev-stimulatory"}, {"source": "ENSG00000137033", "target": "ENSG00000196415", "reverse": "rev-directed"}, {"source": "ENSG00000137033", "target": "ENSG00000197561", "reverse": "rev-directed"}, {"source": "ENSG00000137496", "type": "inhibitory", "target": "ENSG00000150782", "reverse": "rev-directed"}, {"source": "ENSG00000150782", "type": "stimulatory", "target": "ENSG00000196415", "reverse": "rev-directed"}, {"source": "ENSG00000169429", "target": "ENSG00000197561", "reverse": "rev-stimulatory"}, {"source": "ENSG00000197249", "target": "ENSG00000197561"}], "drugs": [{"indications": [{"efo_term": "CHRONIC KIDNEY DISEASE", "stage": 3}, {"efo_term": "PERIPHERAL ARTERIAL DISEASE", "stage": 1}], "max_phase": 3, "name": "VONAPANITASE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545070", "mechanisms": ["Elastin proteolytic enzyme"], "genes": ["ELN"], "type": "Enzyme", "diseases": ["PERIPHERAL ARTERIAL DISEASE", "CHRONIC KIDNEY DISEASE"]}, {"indications": [{"efo_term": "ALZHEIMERS DISEASE", "stage": 1}], "max_phase": 1, "name": "ALEPLASININ", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL325424", "mechanisms": ["Plasminogen activator inhibitor-1 inhibitor"], "genes": ["SERPINE1"], "type": "Small molecule", "diseases": ["ALZHEIMERS DISEASE"]}, {"indications": [{"efo_term": "NEOPLASM", "stage": 1}], "max_phase": 2, "name": "HuMax-IL8", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2109617", "mechanisms": ["Interleukin-8 inhibitor"], "genes": ["CXCL8"], "type": "Antibody", "diseases": ["NEOPLASM"]}, {"indications": [], "max_phase": 2, "name": "ABX-IL8", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2109616", "mechanisms": ["Interleukin-8 inhibitor"], "genes": ["CXCL8"], "type": "Antibody", "diseases": []}], "heat": 0.02970198819262353, "nodes": [{"assoc": 0.045237, "id": "ENSG00000008517", "label": "IL32"}, {"assoc": 0.014184, "id": "ENSG00000010438", "label": "PRSS3"}, {"assoc": 0.031442, "id": "ENSG00000021355", "label": "SERPINB1"}, {"assoc": 0.0190455555556, "id": "ENSG00000049540", "label": "ELN"}, {"assoc": 0.02364, "id": "ENSG00000099953", "label": "MMP11"}, {"assoc": 0.0344, "id": "ENSG00000100448", "label": "CTSG"}, {"assoc": 0.023064, "id": "ENSG00000106366", "label": "SERPINE1"}, {"assoc": 0.0184, "id": "ENSG00000124107", "label": "SLPI"}, {"assoc": 0.021168, "id": "ENSG00000137033", "label": "IL33"}, {"assoc": 0.038018, "id": "ENSG00000137496", "label": "IL18BP"}, {"assoc": 0.014184, "id": "ENSG00000149968", "label": "MMP3"}, {"assoc": 0.0238585, "id": "ENSG00000150782", "label": "IL18"}, {"assoc": 0.017424, "id": "ENSG00000164251", "label": "F2RL1"}, {"assoc": 0.0406480383333, "id": "ENSG00000169429", "label": "CXCL8"}, {"assoc": 0.0669803020276, "id": "ENSG00000196415", "label": "PRTN3"}, {"assoc": 0.0518891811359, "id": "ENSG00000197249", "label": "SERPINA1"}, {"assoc": 0.0213512222222, "id": "ENSG00000197561", "label": "ELANE"}], "size": 17}, {"diseases": ["HIV INFECTION", "RHEUMATOID ARTHRITIS", "CUTANEOUS T-CELL LYMPHOMA", "LYMPHOMA", "DIFFUSE SCLERODERMA", "SYSTEMIC LUPUS ERYTHEMATOSUS", "ANKYLOSING SPONDYLITIS", "CROHN'S DISEASE", "MULTIPLE SCLEROSIS", "VITILIGO", "HYPERTENSION", "PSORIATIC ARTHRITIS", "ULCERATIVE COLITIS", "ACUTE GRAFT VS. HOST DISEASE", "ALOPECIA AREATA", "TYPE I DIABETES MELLITUS", "ASTHMA", "CHRONIC CHILDHOOD ARTHRITIS", "WEGENER'S GRANULOMATOSIS", "ALOPECIA TOTALIS", "ANTI-NEUTROPHIL ANTIBODY ASSOCIATED VASCULITIS", "IMMUNE SYSTEM DISEASE", "PSORIASIS", "SARCOIDOSIS", "RELAPSING-REMITTING MULTIPLE SCLEROSIS", "NEPHROTIC SYNDROME", "UVEITIS", "URTICARIA", "PROTEINURIA", "NON-HODGKINS LYMPHOMA", "HIV-1 INFECTION", "AIDS DEMENTIA", "HYPERTRIGLYCERIDEMIA", "AIDS", "VIRAL DISEASE", "SCLEROSING CHOLANGITIS", "DIABETIC NEPHROPATHY", "RENAL INSUFFICIENCY", "CANCER", "CARCINOMA", "MELANOMA", "PROSTATE CARCINOMA", "METASTATIC MELANOMA", "NON-SMALL CELL LUNG CARCINOMA", "PANCREATIC CARCINOMA", "NEOPLASM", "CHRONIC MYELOGENOUS LEUKEMIA", "CUTANEOUS MELANOMA", "PROSTATE ADENOCARCINOMA", "SMALL CELL LUNG CARCINOMA", "BREAST CARCINOMA", "LUNG CARCINOMA", "GASTRIC ADENOCARCINOMA", "RENAL CARCINOMA", "HEAD AND NECK SQUAMOUS CELL CARCINOMA", "MERKEL CELL SKIN CANCER", "HEPATOCELLULAR CARCINOMA", "MESOTHELIOMA", "GLIOBLASTOMA MULTIFORME", "MYELODYSPLASTIC SYNDROME", "GASTRIC CARCINOMA", "MYELOPROLIFERATIVE DISORDER", "RENAL CELL CARCINOMA", "BRAIN NEOPLASM", "MENINGIOMA", "COLORECTAL ADENOCARCINOMA", "LEIOMYOSARCOMA", "SARCOMA", "ACUTE MYELOID LEUKEMIA", "MALIGNANT PLEURAL MESOTHELIOMA", "ESOPHAGEAL CARCINOMA", "CLEAR CELL RENAL CARCINOMA", "SQUAMOUS CELL LUNG CARCINOMA", "SEPSIS", "T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA", "GASTROINTESTINAL STROMAL TUMOR", "CENTRAL NERVOUS SYSTEM CANCER", "BLADDER CARCINOMA", "BILIARY TRACT NEOPLASM", "OVARIAN NEOPLASM", "HODGKINS LYMPHOMA", "NASOPHARYNGEAL NEOPLASM", "NEOPLASM OF MATURE B-CELLS", "THYROID CARCINOMA", "ADRENOCORTICAL CARCINOMA", "OSTEOSARCOMA", "SQUAMOUS CELL CARCINOMA", "MULTIPLE MYELOMA", "BASAL CELL CARCINOMA", "ENDOMETRIAL NEOPLASM", "GLIOSARCOMA", "OVARIAN CARCINOMA", "UPPER AERODIGESTIVE TRACT NEOPLASM", "SALIVARY GLAND NEOPLASM", "SKIN NEOPLASM", "UTERINE NEOPLASM", "BREAST NEOPLASM", "MALIGNANT PERITONEAL MESOTHELIOMA", "FAMILIAL ADENOMATOUS POLYPOSIS", "MALE BREAST CARCINOMA", "ADENOID CYSTIC CARCINOMA", "ADENOCARCINOMA", "RECTUM CANCER", "CARCINOID SYNDROME", "CHOLANGIOCARCINOMA", "COLORECTAL CANCER", "THYROID NEOPLASM", "NEUROBLASTOMA", "LEUKEMIA", "ABNORMALITY OF BLOOD AND BLOOD-FORMING TISSUES", "CHRONIC LYMPHOCYTIC LEUKEMIA", "ACUTE LYMPHOBLASTIC LEUKEMIA", "SYSTEMIC SCLERODERMA", "DIFFUSE LARGE B-CELL LYMPHOMA", "POLYCYTHEMIA VERA", "CHRONIC KIDNEY DISEASE", "PANCREATIC DUCTAL ADENOCARCINOMA", "PRIMARY MYELOFIBROSIS", "LYMPHOID NEOPLASM", "HEREDITARY BREAST AND OVARIAN CANCER SYNDROME"], "links": [{"source": "ENSG00000006210", "type": "stimulatory", "target": "ENSG00000168329"}, {"source": "ENSG00000006606", "type": "stimulatory", "target": "ENSG00000160791"}, {"source": "ENSG00000006606", "type": "stimulatory", "target": "ENSG00000168329"}, {"source": "ENSG00000006606", "type": "stimulatory", "target": "ENSG00000183625"}, {"source": "ENSG00000010610", "type": "stimulatory", "target": "ENSG00000160791", "reverse": "rev-stimulatory"}, {"source": "ENSG00000010610", "type": "stimulatory", "target": "ENSG00000178562", "reverse": "rev-inhibitory"}, {"source": "ENSG00000114013", "type": "stimulatory", "target": "ENSG00000163599", "reverse": "rev-directed"}, {"source": "ENSG00000114013", "type": "stimulatory", "target": "ENSG00000178562", "reverse": "rev-directed"}, {"source": "ENSG00000121594", "type": "stimulatory", "target": "ENSG00000163599", "reverse": "rev-directed"}, {"source": "ENSG00000121594", "type": "stimulatory", "target": "ENSG00000178562", "reverse": "rev-stimulatory"}, {"source": "ENSG00000151882", "type": "stimulatory", "target": "ENSG00000183625"}, {"source": "ENSG00000169245", "type": "stimulatory", "target": "ENSG00000183625"}, {"source": "ENSG00000223865", "type": "manual", "target": "ENSG00000231389"}, {"source": "ENSG00000231389", "type": "manual", "target": "ENSG00000010610"}, {"source": "ENSG00000188389", "type": "manual", "target": "ENSG00000185338"}, {"source": "ENSG00000185338", "type": "manual", "target": "ENSG00000146648"}, {"source": "ENSG00000146648", "type": "manual", "target": "ENSG00000101336"}, {"source": "ENSG00000101336", "type": "manual", "target": "ENSG00000183625"}, {"source": "ENSG00000188389", "type": "manual", "target": "ENSG00000111679"}, {"source": "ENSG00000111679", "type": "manual", "target": "ENSG00000146648"}, {"source": "ENSG00000188389", "type": "manual", "target": "ENSG00000120217"}, {"source": "ENSG00000120217", "type": "manual", "target": "ENSG00000121594"}, {"source": "ENSG00000188389", "type": "manual", "target": "ENSG00000196092"}, {"source": "ENSG00000196092", "type": "manual", "target": "ENSG00000134954"}, {"source": "ENSG00000134954", "type": "manual", "target": "ENSG00000141510"}, {"source": "ENSG00000141510", "type": "manual", "target": "ENSG00000006210"}], "drugs": [{"indications": [{"efo_term": "MELANOMA", "stage": 4}, {"efo_term": "METASTATIC MELANOMA", "stage": 4}, {"efo_term": "CANCER", "stage": 4}, {"efo_term": "NEOPLASM", "stage": 4}, {"efo_term": "CUTANEOUS MELANOMA", "stage": 4}, {"efo_term": "NON-SMALL CELL LUNG CARCINOMA", "stage": 3}, {"efo_term": "HEAD AND NECK SQUAMOUS CELL CARCINOMA", "stage": 3}, {"efo_term": "HEPATOCELLULAR CARCINOMA", "stage": 3}, {"efo_term": "GASTRIC ADENOCARCINOMA", "stage": 3}, {"efo_term": "HODGKINS LYMPHOMA", "stage": 3}, {"efo_term": "BREAST CARCINOMA", "stage": 3}, {"efo_term": "COLORECTAL ADENOCARCINOMA", "stage": 3}, {"efo_term": "ESOPHAGEAL CARCINOMA", "stage": 3}, {"efo_term": "SQUAMOUS CELL CARCINOMA", "stage": 3}, {"efo_term": "RENAL CELL CARCINOMA", "stage": 2}, {"efo_term": "OVARIAN NEOPLASM", "stage": 2}, {"efo_term": "BLADDER CARCINOMA", "stage": 2}, {"efo_term": "MESOTHELIOMA", "stage": 2}, {"efo_term": "NASOPHARYNGEAL NEOPLASM", "stage": 2}, {"efo_term": "GLIOBLASTOMA MULTIFORME", "stage": 2}, {"efo_term": "CARCINOMA", "stage": 2}, {"efo_term": "SMALL CELL LUNG CARCINOMA", "stage": 2}, {"efo_term": "THYROID CARCINOMA", "stage": 2}, {"efo_term": "ADRENOCORTICAL CARCINOMA", "stage": 2}, {"efo_term": "ACUTE MYELOID LEUKEMIA", "stage": 2}, {"efo_term": "OSTEOSARCOMA", "stage": 2}, {"efo_term": "MULTIPLE MYELOMA", "stage": 2}, {"efo_term": "BASAL CELL CARCINOMA", "stage": 2}, {"efo_term": "T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA", "stage": 2}, {"efo_term": "ENDOMETRIAL NEOPLASM", "stage": 2}, {"efo_term": "GLIOSARCOMA", "stage": 2}, {"efo_term": "OVARIAN CARCINOMA", "stage": 2}, {"efo_term": "PROSTATE CARCINOMA", "stage": 2}, {"efo_term": "MALIGNANT PLEURAL MESOTHELIOMA", "stage": 2}, {"efo_term": "MERKEL CELL SKIN CANCER", "stage": 2}, {"efo_term": "PANCREATIC CARCINOMA", "stage": 1}, {"efo_term": "NEOPLASM OF MATURE B-CELLS", "stage": 1}, {"efo_term": "LUNG CARCINOMA", "stage": 1}], "max_phase": 4, "name": "PEMBROLIZUMAB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3137343", "mechanisms": ["Programmed cell death protein 1 inhibitor"], "genes": ["PDCD1"], "type": "Antibody", "diseases": ["MELANOMA", "NON-SMALL CELL LUNG CARCINOMA", "PANCREATIC CARCINOMA", "METASTATIC MELANOMA", "RENAL CELL CARCINOMA", "CANCER", "OVARIAN NEOPLASM", "NEOPLASM", "HEAD AND NECK SQUAMOUS CELL CARCINOMA", "HEPATOCELLULAR CARCINOMA", "BLADDER CARCINOMA", "GASTRIC ADENOCARCINOMA", "MESOTHELIOMA", "HODGKINS LYMPHOMA", "BREAST CARCINOMA", "COLORECTAL ADENOCARCINOMA", "NASOPHARYNGEAL NEOPLASM", "NEOPLASM OF MATURE B-CELLS", "GLIOBLASTOMA MULTIFORME", "ESOPHAGEAL CARCINOMA", "CARCINOMA", "SMALL CELL LUNG CARCINOMA", "THYROID CARCINOMA", "ADRENOCORTICAL CARCINOMA", "LUNG CARCINOMA", "ACUTE MYELOID LEUKEMIA", "OSTEOSARCOMA", "SQUAMOUS CELL CARCINOMA", "CUTANEOUS MELANOMA", "MULTIPLE MYELOMA", "BASAL CELL CARCINOMA", "T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA", "ENDOMETRIAL NEOPLASM", "GLIOSARCOMA", "OVARIAN CARCINOMA", "PROSTATE CARCINOMA", "MALIGNANT PLEURAL MESOTHELIOMA", "MERKEL CELL SKIN CANCER"]}, {"indications": [{"efo_term": "NON-SMALL CELL LUNG CARCINOMA", "stage": 4}, {"efo_term": "MELANOMA", "stage": 4}, {"efo_term": "CUTANEOUS MELANOMA", "stage": 4}, {"efo_term": "METASTATIC MELANOMA", "stage": 4}, {"efo_term": "NEOPLASM", "stage": 4}, {"efo_term": "CANCER", "stage": 4}, {"efo_term": "GASTRIC CARCINOMA", "stage": 3}, {"efo_term": "HEAD AND NECK SQUAMOUS CELL CARCINOMA", "stage": 3}, {"efo_term": "RENAL CARCINOMA", "stage": 3}, {"efo_term": "RENAL CELL CARCINOMA", "stage": 3}, {"efo_term": "LUNG CARCINOMA", "stage": 3}, {"efo_term": "BRAIN NEOPLASM", "stage": 3}, {"efo_term": "GLIOBLASTOMA MULTIFORME", "stage": 3}, {"efo_term": "ESOPHAGEAL CARCINOMA", "stage": 3}, {"efo_term": "CLEAR CELL RENAL CARCINOMA", "stage": 3}, {"efo_term": "HEPATOCELLULAR CARCINOMA", "stage": 3}, {"efo_term": "SQUAMOUS CELL LUNG CARCINOMA", "stage": 3}, {"efo_term": "NON-HODGKINS LYMPHOMA", "stage": 2}, {"efo_term": "LYMPHOMA", "stage": 2}, {"efo_term": "MYELOPROLIFERATIVE DISORDER", "stage": 2}, {"efo_term": "MENINGIOMA", "stage": 2}, {"efo_term": "BREAST CARCINOMA", "stage": 2}, {"efo_term": "LEIOMYOSARCOMA", "stage": 2}, {"efo_term": "SARCOMA", "stage": 2}, {"efo_term": "ACUTE MYELOID LEUKEMIA", "stage": 2}, {"efo_term": "MALIGNANT PLEURAL MESOTHELIOMA", "stage": 2}, {"efo_term": "MESOTHELIOMA", "stage": 2}, {"efo_term": "PANCREATIC CARCINOMA", "stage": 2}, {"efo_term": "T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA", "stage": 2}, {"efo_term": "GASTROINTESTINAL STROMAL TUMOR", "stage": 2}, {"efo_term": "BLADDER CARCINOMA", "stage": 2}, {"efo_term": "BILIARY TRACT NEOPLASM", "stage": 2}, {"efo_term": "COLORECTAL ADENOCARCINOMA", "stage": 1}, {"efo_term": "SMALL CELL LUNG CARCINOMA", "stage": 1}, {"efo_term": "SEPSIS", "stage": 1}, {"efo_term": "PROSTATE CARCINOMA", "stage": 1}, {"efo_term": "CENTRAL NERVOUS SYSTEM CANCER", "stage": 1}], "max_phase": 4, "name": "NIVOLUMAB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2108738", "mechanisms": ["Programmed cell death protein 1 inhibitor"], "genes": ["PDCD1"], "type": "Antibody", "diseases": ["NON-HODGKINS LYMPHOMA", "NON-SMALL CELL LUNG CARCINOMA", "GASTRIC CARCINOMA", "MELANOMA", "CUTANEOUS MELANOMA", "METASTATIC MELANOMA", "HEAD AND NECK SQUAMOUS CELL CARCINOMA", "LYMPHOMA", "RENAL CARCINOMA", "MYELOPROLIFERATIVE DISORDER", "NEOPLASM", "CANCER", "RENAL CELL CARCINOMA", "LUNG CARCINOMA", "BRAIN NEOPLASM", "MENINGIOMA", "BREAST CARCINOMA", "COLORECTAL ADENOCARCINOMA", "LEIOMYOSARCOMA", "SARCOMA", "ACUTE MYELOID LEUKEMIA", "GLIOBLASTOMA MULTIFORME", "MALIGNANT PLEURAL MESOTHELIOMA", "MESOTHELIOMA", "ESOPHAGEAL CARCINOMA", "CLEAR CELL RENAL CARCINOMA", "SMALL CELL LUNG CARCINOMA", "HEPATOCELLULAR CARCINOMA", "PANCREATIC CARCINOMA", "SQUAMOUS CELL LUNG CARCINOMA", "SEPSIS", "T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA", "GASTROINTESTINAL STROMAL TUMOR", "PROSTATE CARCINOMA", "CENTRAL NERVOUS SYSTEM CANCER", "BLADDER CARCINOMA", "BILIARY TRACT NEOPLASM"]}, {"indications": [{"efo_term": "ACUTE LYMPHOBLASTIC LEUKEMIA", "stage": 4}, {"efo_term": "CANCER", "stage": 4}, {"efo_term": "NEOPLASM", "stage": 4}, {"efo_term": "LEUKEMIA", "stage": 3}, {"efo_term": "CHRONIC MYELOGENOUS LEUKEMIA", "stage": 3}, {"efo_term": "ABNORMALITY OF BLOOD AND BLOOD-FORMING TISSUES", "stage": 2}, {"efo_term": "CHRONIC LYMPHOCYTIC LEUKEMIA", "stage": 2}, {"efo_term": "MULTIPLE MYELOMA", "stage": 2}, {"efo_term": "NON-SMALL CELL LUNG CARCINOMA", "stage": 2}, {"efo_term": "PANCREATIC CARCINOMA", "stage": 2}, {"efo_term": "SQUAMOUS CELL LUNG CARCINOMA", "stage": 2}, {"efo_term": "BREAST CARCINOMA", "stage": 2}, {"efo_term": "PROSTATE CARCINOMA", "stage": 2}, {"efo_term": "LUNG CARCINOMA", "stage": 2}, {"efo_term": "METASTATIC MELANOMA", "stage": 2}, {"efo_term": "ACUTE MYELOID LEUKEMIA", "stage": 2}, {"efo_term": "MALIGNANT PLEURAL MESOTHELIOMA", "stage": 2}, {"efo_term": "DIFFUSE LARGE B-CELL LYMPHOMA", "stage": 2}, {"efo_term": "MELANOMA", "stage": 2}, {"efo_term": "MESOTHELIOMA", "stage": 2}, {"efo_term": "POLYCYTHEMIA VERA", "stage": 2}, {"efo_term": "BREAST NEOPLASM", "stage": 2}, {"efo_term": "HEPATOCELLULAR CARCINOMA", "stage": 2}, {"efo_term": "LYMPHOMA", "stage": 2}, {"efo_term": "SMALL CELL LUNG CARCINOMA", "stage": 2}, {"efo_term": "PROSTATE ADENOCARCINOMA", "stage": 2}, {"efo_term": "CHOLANGIOCARCINOMA", "stage": 2}, {"efo_term": "CHRONIC KIDNEY DISEASE", "stage": 2}, {"efo_term": "GLIOSARCOMA", "stage": 2}, {"efo_term": "NON-HODGKINS LYMPHOMA", "stage": 1}, {"efo_term": "GLIOBLASTOMA MULTIFORME", "stage": 1}, {"efo_term": "SYSTEMIC SCLERODERMA", "stage": 1}], "max_phase": 4, "name": "DASATINIB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1421", "mechanisms": ["SRC inhibitor"], "genes": ["HCK"], "type": "Small molecule", "diseases": ["ABNORMALITY OF BLOOD AND BLOOD-FORMING TISSUES", "CHRONIC LYMPHOCYTIC LEUKEMIA", "LEUKEMIA", "MULTIPLE MYELOMA", "NON-HODGKINS LYMPHOMA", "NON-SMALL CELL LUNG CARCINOMA", "PANCREATIC CARCINOMA", "SQUAMOUS CELL LUNG CARCINOMA", "BREAST CARCINOMA", "CHRONIC MYELOGENOUS LEUKEMIA", "PROSTATE CARCINOMA", "ACUTE LYMPHOBLASTIC LEUKEMIA", "GLIOBLASTOMA MULTIFORME", "LUNG CARCINOMA", "METASTATIC MELANOMA", "SYSTEMIC SCLERODERMA", "ACUTE MYELOID LEUKEMIA", "CANCER", "MALIGNANT PLEURAL MESOTHELIOMA", "NEOPLASM", "DIFFUSE LARGE B-CELL LYMPHOMA", "MELANOMA", "MESOTHELIOMA", "POLYCYTHEMIA VERA", "BREAST NEOPLASM", "HEPATOCELLULAR CARCINOMA", "LYMPHOMA", "SMALL CELL LUNG CARCINOMA", "PROSTATE ADENOCARCINOMA", "CHOLANGIOCARCINOMA", "CHRONIC KIDNEY DISEASE", "GLIOSARCOMA"]}, {"indications": [{"efo_term": "RHEUMATOID ARTHRITIS", "stage": 4}, {"efo_term": "CHRONIC CHILDHOOD ARTHRITIS", "stage": 4}, {"efo_term": "IMMUNE SYSTEM DISEASE", "stage": 4}, {"efo_term": "CROHN'S DISEASE", "stage": 3}, {"efo_term": "PSORIATIC ARTHRITIS", "stage": 3}, {"efo_term": "ULCERATIVE COLITIS", "stage": 3}, {"efo_term": "DIFFUSE SCLERODERMA", "stage": 2}, {"efo_term": "SYSTEMIC LUPUS ERYTHEMATOSUS", "stage": 2}, {"efo_term": "ANKYLOSING SPONDYLITIS", "stage": 2}, {"efo_term": "MULTIPLE SCLEROSIS", "stage": 2}, {"efo_term": "HYPERTENSION", "stage": 2}, {"efo_term": "ALOPECIA AREATA", "stage": 2}, {"efo_term": "TYPE I DIABETES MELLITUS", "stage": 2}, {"efo_term": "ASTHMA", "stage": 2}, {"efo_term": "ALOPECIA TOTALIS", "stage": 2}, {"efo_term": "ANTI-NEUTROPHIL ANTIBODY ASSOCIATED VASCULITIS", "stage": 2}, {"efo_term": "PSORIASIS", "stage": 2}, {"efo_term": "SARCOIDOSIS", "stage": 2}, {"efo_term": "RELAPSING-REMITTING MULTIPLE SCLEROSIS", "stage": 2}, {"efo_term": "NEPHROTIC SYNDROME", "stage": 2}, {"efo_term": "UVEITIS", "stage": 2}, {"efo_term": "VITILIGO", "stage": 1}, {"efo_term": "ACUTE GRAFT VS. HOST DISEASE", "stage": 1}, {"efo_term": "WEGENER'S GRANULOMATOSIS", "stage": 1}, {"efo_term": "URTICARIA", "stage": 1}], "max_phase": 4, "name": "ABATACEPT", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201823", "mechanisms": ["T-lymphocyte activation antigen CD86 inhibitor", "T-lymphocyte activation antigen CD80 inhibitor"], "genes": ["CD86", "CD80"], "type": "Protein", "diseases": ["DIFFUSE SCLERODERMA", "RHEUMATOID ARTHRITIS", "SYSTEMIC LUPUS ERYTHEMATOSUS", "ANKYLOSING SPONDYLITIS", "CROHN'S DISEASE", "MULTIPLE SCLEROSIS", "VITILIGO", "HYPERTENSION", "PSORIATIC ARTHRITIS", "ULCERATIVE COLITIS", "ACUTE GRAFT VS. HOST DISEASE", "ALOPECIA AREATA", "TYPE I DIABETES MELLITUS", "ASTHMA", "CHRONIC CHILDHOOD ARTHRITIS", "WEGENER'S GRANULOMATOSIS", "ALOPECIA TOTALIS", "ANTI-NEUTROPHIL ANTIBODY ASSOCIATED VASCULITIS", "IMMUNE SYSTEM DISEASE", "PSORIASIS", "SARCOIDOSIS", "RELAPSING-REMITTING MULTIPLE SCLEROSIS", "NEPHROTIC SYNDROME", "UVEITIS", "URTICARIA"]}, {"indications": [{"efo_term": "CANCER", "stage": 4}, {"efo_term": "COLORECTAL ADENOCARCINOMA", "stage": 4}, {"efo_term": "NEOPLASM", "stage": 4}, {"efo_term": "HEAD AND NECK SQUAMOUS CELL CARCINOMA", "stage": 3}, {"efo_term": "NON-SMALL CELL LUNG CARCINOMA", "stage": 3}, {"efo_term": "SQUAMOUS CELL CARCINOMA", "stage": 3}, {"efo_term": "LUNG CARCINOMA", "stage": 3}, {"efo_term": "GASTRIC ADENOCARCINOMA", "stage": 2}, {"efo_term": "HEPATOCELLULAR CARCINOMA", "stage": 2}, {"efo_term": "NASOPHARYNGEAL NEOPLASM", "stage": 2}, {"efo_term": "ESOPHAGEAL CARCINOMA", "stage": 2}, {"efo_term": "GASTRIC CARCINOMA", "stage": 2}, {"efo_term": "ADENOCARCINOMA", "stage": 2}, {"efo_term": "ENDOMETRIAL NEOPLASM", "stage": 2}, {"efo_term": "GLIOBLASTOMA MULTIFORME", "stage": 2}, {"efo_term": "SARCOMA", "stage": 2}, {"efo_term": "OVARIAN CARCINOMA", "stage": 2}, {"efo_term": "BREAST CARCINOMA", "stage": 2}, {"efo_term": "PANCREATIC CARCINOMA", "stage": 2}, {"efo_term": "RECTUM CANCER", "stage": 2}, {"efo_term": "UPPER AERODIGESTIVE TRACT NEOPLASM", "stage": 1}, {"efo_term": "ADENOID CYSTIC CARCINOMA", "stage": 1}], "max_phase": 4, "name": "CETUXIMAB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201577", "mechanisms": ["Epidermal growth factor receptor erbB1 inhibitor"], "genes": ["EGFR"], "type": "Antibody", "diseases": ["CANCER", "COLORECTAL ADENOCARCINOMA", "GASTRIC ADENOCARCINOMA", "HEAD AND NECK SQUAMOUS CELL CARCINOMA", "NEOPLASM", "NON-SMALL CELL LUNG CARCINOMA", "SQUAMOUS CELL CARCINOMA", "UPPER AERODIGESTIVE TRACT NEOPLASM", "HEPATOCELLULAR CARCINOMA", "NASOPHARYNGEAL NEOPLASM", "ADENOID CYSTIC CARCINOMA", "ESOPHAGEAL CARCINOMA", "GASTRIC CARCINOMA", "LUNG CARCINOMA", "ADENOCARCINOMA", "ENDOMETRIAL NEOPLASM", "GLIOBLASTOMA MULTIFORME", "SARCOMA", "OVARIAN CARCINOMA", "BREAST CARCINOMA", "PANCREATIC CARCINOMA", "RECTUM CANCER"]}, {"indications": [{"efo_term": "CANCER", "stage": 3}, {"efo_term": "NEOPLASM", "stage": 3}, {"efo_term": "NON-SMALL CELL LUNG CARCINOMA", "stage": 3}, {"efo_term": "HEAD AND NECK SQUAMOUS CELL CARCINOMA", "stage": 3}, {"efo_term": "SQUAMOUS CELL LUNG CARCINOMA", "stage": 3}, {"efo_term": "BREAST CARCINOMA", "stage": 2}, {"efo_term": "ESOPHAGEAL CARCINOMA", "stage": 2}, {"efo_term": "BREAST NEOPLASM", "stage": 2}, {"efo_term": "BLADDER CARCINOMA", "stage": 2}, {"efo_term": "GLIOBLASTOMA MULTIFORME", "stage": 2}, {"efo_term": "OVARIAN CARCINOMA", "stage": 2}, {"efo_term": "PANCREATIC DUCTAL ADENOCARCINOMA", "stage": 2}, {"efo_term": "PROSTATE CARCINOMA", "stage": 2}, {"efo_term": "COLORECTAL CANCER", "stage": 2}, {"efo_term": "PANCREATIC CARCINOMA", "stage": 2}, {"efo_term": "MESOTHELIOMA", "stage": 2}, {"efo_term": "HEPATOCELLULAR CARCINOMA", "stage": 2}, {"efo_term": "GASTRIC ADENOCARCINOMA", "stage": 1}, {"efo_term": "MELANOMA", "stage": 1}, {"efo_term": "DIFFUSE LARGE B-CELL LYMPHOMA", "stage": 1}, {"efo_term": "MULTIPLE MYELOMA", "stage": 1}, {"efo_term": "PRIMARY MYELOFIBROSIS", "stage": 1}], "max_phase": 3, "name": "DURVALUMAB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3301587", "mechanisms": ["Programmed cell death 1 ligand 1 inhibitor"], "genes": ["CD274"], "type": "Antibody", "diseases": ["BREAST CARCINOMA", "CANCER", "GASTRIC ADENOCARCINOMA", "NEOPLASM", "MELANOMA", "ESOPHAGEAL CARCINOMA", "NON-SMALL CELL LUNG CARCINOMA", "BREAST NEOPLASM", "BLADDER CARCINOMA", "DIFFUSE LARGE B-CELL LYMPHOMA", "GLIOBLASTOMA MULTIFORME", "HEAD AND NECK SQUAMOUS CELL CARCINOMA", "MULTIPLE MYELOMA", "OVARIAN CARCINOMA", "PANCREATIC DUCTAL ADENOCARCINOMA", "PRIMARY MYELOFIBROSIS", "PROSTATE CARCINOMA", "SQUAMOUS CELL LUNG CARCINOMA", "COLORECTAL CANCER", "PANCREATIC CARCINOMA", "MESOTHELIOMA", "HEPATOCELLULAR CARCINOMA"]}, {"indications": [{"efo_term": "LUNG CARCINOMA", "stage": 3}, {"efo_term": "NON-SMALL CELL LUNG CARCINOMA", "stage": 3}, {"efo_term": "BREAST CARCINOMA", "stage": 2}, {"efo_term": "CARCINOMA", "stage": 2}, {"efo_term": "HEAD AND NECK SQUAMOUS CELL CARCINOMA", "stage": 2}, {"efo_term": "MALIGNANT PERITONEAL MESOTHELIOMA", "stage": 2}, {"efo_term": "PANCREATIC CARCINOMA", "stage": 2}, {"efo_term": "BRAIN NEOPLASM", "stage": 2}, {"efo_term": "RENAL CARCINOMA", "stage": 2}, {"efo_term": "BLADDER CARCINOMA", "stage": 2}, {"efo_term": "HEPATOCELLULAR CARCINOMA", "stage": 2}, {"efo_term": "PROSTATE CARCINOMA", "stage": 2}, {"efo_term": "MESOTHELIOMA", "stage": 2}, {"efo_term": "RENAL CELL CARCINOMA", "stage": 2}, {"efo_term": "ESOPHAGEAL CARCINOMA", "stage": 2}, {"efo_term": "SQUAMOUS CELL LUNG CARCINOMA", "stage": 2}, {"efo_term": "FAMILIAL ADENOMATOUS POLYPOSIS", "stage": 2}, {"efo_term": "CANCER", "stage": 1}, {"efo_term": "CENTRAL NERVOUS SYSTEM CANCER", "stage": 1}], "max_phase": 4, "name": "ERLOTINIB HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1079742", "mechanisms": ["Epidermal growth factor receptor erbB1 inhibitor"], "genes": ["EGFR"], "type": "Small molecule", "diseases": ["BREAST CARCINOMA", "CARCINOMA", "HEAD AND NECK SQUAMOUS CELL CARCINOMA", "LUNG CARCINOMA", "NON-SMALL CELL LUNG CARCINOMA", "MALIGNANT PERITONEAL MESOTHELIOMA", "PANCREATIC CARCINOMA", "BRAIN NEOPLASM", "CANCER", "CENTRAL NERVOUS SYSTEM CANCER", "RENAL CARCINOMA", "BLADDER CARCINOMA", "HEPATOCELLULAR CARCINOMA", "PROSTATE CARCINOMA", "MESOTHELIOMA", "RENAL CELL CARCINOMA", "ESOPHAGEAL CARCINOMA", "SQUAMOUS CELL LUNG CARCINOMA", "FAMILIAL ADENOMATOUS POLYPOSIS"]}, {"indications": [{"efo_term": "CANCER", "stage": 4}, {"efo_term": "MELANOMA", "stage": 4}, {"efo_term": "METASTATIC MELANOMA", "stage": 4}, {"efo_term": "NEOPLASM", "stage": 4}, {"efo_term": "CUTANEOUS MELANOMA", "stage": 4}, {"efo_term": "PROSTATE CARCINOMA", "stage": 3}, {"efo_term": "PROSTATE ADENOCARCINOMA", "stage": 3}, {"efo_term": "NON-SMALL CELL LUNG CARCINOMA", "stage": 2}, {"efo_term": "SMALL CELL LUNG CARCINOMA", "stage": 2}, {"efo_term": "LUNG CARCINOMA", "stage": 2}, {"efo_term": "GASTRIC ADENOCARCINOMA", "stage": 2}, {"efo_term": "MERKEL CELL SKIN CANCER", "stage": 2}, {"efo_term": "CARCINOMA", "stage": 1}, {"efo_term": "PANCREATIC CARCINOMA", "stage": 1}, {"efo_term": "CHRONIC MYELOGENOUS LEUKEMIA", "stage": 1}, {"efo_term": "BREAST CARCINOMA", "stage": 1}, {"efo_term": "RENAL CARCINOMA", "stage": 1}, {"efo_term": "HEAD AND NECK SQUAMOUS CELL CARCINOMA", "stage": 1}], "max_phase": 4, "name": "IPILIMUMAB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1789844", "mechanisms": ["Cytotoxic T-lymphocyte protein 4 inhibitor"], "genes": ["CTLA4"], "type": "Antibody", "diseases": ["CANCER", "CARCINOMA", "MELANOMA", "PROSTATE CARCINOMA", "METASTATIC MELANOMA", "NON-SMALL CELL LUNG CARCINOMA", "PANCREATIC CARCINOMA", "NEOPLASM", "CHRONIC MYELOGENOUS LEUKEMIA", "CUTANEOUS MELANOMA", "PROSTATE ADENOCARCINOMA", "SMALL CELL LUNG CARCINOMA", "BREAST CARCINOMA", "LUNG CARCINOMA", "GASTRIC ADENOCARCINOMA", "RENAL CARCINOMA", "HEAD AND NECK SQUAMOUS CELL CARCINOMA", "MERKEL CELL SKIN CANCER"]}, {"indications": [{"efo_term": "NEOPLASM", "stage": 4}, {"efo_term": "CANCER", "stage": 4}, {"efo_term": "NON-SMALL CELL LUNG CARCINOMA", "stage": 3}, {"efo_term": "LUNG CARCINOMA", "stage": 3}, {"efo_term": "BREAST CARCINOMA", "stage": 2}, {"efo_term": "UPPER AERODIGESTIVE TRACT NEOPLASM", "stage": 2}, {"efo_term": "SQUAMOUS CELL CARCINOMA", "stage": 2}, {"efo_term": "ACUTE MYELOID LEUKEMIA", "stage": 2}, {"efo_term": "CENTRAL NERVOUS SYSTEM CANCER", "stage": 2}, {"efo_term": "SALIVARY GLAND NEOPLASM", "stage": 2}, {"efo_term": "SKIN NEOPLASM", "stage": 2}, {"efo_term": "ESOPHAGEAL CARCINOMA", "stage": 2}, {"efo_term": "MESOTHELIOMA", "stage": 2}, {"efo_term": "HEPATOCELLULAR CARCINOMA", "stage": 2}, {"efo_term": "GLIOSARCOMA", "stage": 2}, {"efo_term": "UTERINE NEOPLASM", "stage": 2}], "max_phase": 4, "name": "GEFITINIB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL939", "mechanisms": ["Epidermal growth factor receptor erbB1 inhibitor"], "genes": ["EGFR"], "type": "Small molecule", "diseases": ["BREAST CARCINOMA", "NON-SMALL CELL LUNG CARCINOMA", "UPPER AERODIGESTIVE TRACT NEOPLASM", "LUNG CARCINOMA", "SQUAMOUS CELL CARCINOMA", "ACUTE MYELOID LEUKEMIA", "NEOPLASM", "CENTRAL NERVOUS SYSTEM CANCER", "SALIVARY GLAND NEOPLASM", "SKIN NEOPLASM", "ESOPHAGEAL CARCINOMA", "MESOTHELIOMA", "HEPATOCELLULAR CARCINOMA", "CANCER", "GLIOSARCOMA", "UTERINE NEOPLASM"]}, {"indications": [{"efo_term": "THYROID CARCINOMA", "stage": 4}, {"efo_term": "THYROID NEOPLASM", "stage": 4}, {"efo_term": "NEOPLASM", "stage": 4}, {"efo_term": "CANCER", "stage": 4}, {"efo_term": "NON-SMALL CELL LUNG CARCINOMA", "stage": 3}, {"efo_term": "MESOTHELIOMA", "stage": 2}, {"efo_term": "PANCREATIC CARCINOMA", "stage": 2}, {"efo_term": "PROSTATE CARCINOMA", "stage": 2}, {"efo_term": "GASTROINTESTINAL STROMAL TUMOR", "stage": 2}, {"efo_term": "HEPATOCELLULAR CARCINOMA", "stage": 2}, {"efo_term": "CLEAR CELL RENAL CARCINOMA", "stage": 2}, {"efo_term": "LUNG CARCINOMA", "stage": 2}, {"efo_term": "BREAST CARCINOMA", "stage": 2}, {"efo_term": "CENTRAL NERVOUS SYSTEM CANCER", "stage": 1}, {"efo_term": "OVARIAN CARCINOMA", "stage": 1}, {"efo_term": "NEUROBLASTOMA", "stage": 1}], "max_phase": 4, "name": "VANDETANIB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL24828", "mechanisms": ["Epidermal growth factor receptor inhibitor"], "genes": ["EGFR"], "type": "Small molecule", "diseases": ["MESOTHELIOMA", "CENTRAL NERVOUS SYSTEM CANCER", "PANCREATIC CARCINOMA", "THYROID CARCINOMA", "NON-SMALL CELL LUNG CARCINOMA", "OVARIAN CARCINOMA", "PROSTATE CARCINOMA", "GASTROINTESTINAL STROMAL TUMOR", "THYROID NEOPLASM", "HEPATOCELLULAR CARCINOMA", "NEOPLASM", "CLEAR CELL RENAL CARCINOMA", "NEUROBLASTOMA", "CANCER", "LUNG CARCINOMA", "BREAST CARCINOMA"]}, {"indications": [{"efo_term": "HEAD AND NECK SQUAMOUS CELL CARCINOMA", "stage": 3}, {"efo_term": "NON-SMALL CELL LUNG CARCINOMA", "stage": 3}, {"efo_term": "HEPATOCELLULAR CARCINOMA", "stage": 2}, {"efo_term": "MESOTHELIOMA", "stage": 2}, {"efo_term": "BREAST CARCINOMA", "stage": 2}, {"efo_term": "GLIOBLASTOMA MULTIFORME", "stage": 2}, {"efo_term": "MELANOMA", "stage": 1}, {"efo_term": "METASTATIC MELANOMA", "stage": 1}, {"efo_term": "PANCREATIC CARCINOMA", "stage": 1}, {"efo_term": "NEOPLASM", "stage": 1}, {"efo_term": "GASTRIC ADENOCARCINOMA", "stage": 1}, {"efo_term": "LYMPHOMA", "stage": 1}, {"efo_term": "MYELODYSPLASTIC SYNDROME", "stage": 1}], "max_phase": 3, "name": "TREMELIMUMAB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2108658", "mechanisms": ["Cytotoxic T-lymphocyte protein 4 inhibitor"], "genes": ["CTLA4"], "type": "Antibody", "diseases": ["HEPATOCELLULAR CARCINOMA", "MESOTHELIOMA", "BREAST CARCINOMA", "MELANOMA", "HEAD AND NECK SQUAMOUS CELL CARCINOMA", "METASTATIC MELANOMA", "PANCREATIC CARCINOMA", "NEOPLASM", "NON-SMALL CELL LUNG CARCINOMA", "GLIOBLASTOMA MULTIFORME", "GASTRIC ADENOCARCINOMA", "LYMPHOMA", "MYELODYSPLASTIC SYNDROME"]}, {"indications": [{"efo_term": "MERKEL CELL SKIN CANCER", "stage": 4}, {"efo_term": "GASTRIC ADENOCARCINOMA", "stage": 3}, {"efo_term": "CANCER", "stage": 3}, {"efo_term": "NON-SMALL CELL LUNG CARCINOMA", "stage": 3}, {"efo_term": "NEOPLASM", "stage": 3}, {"efo_term": "OVARIAN CARCINOMA", "stage": 3}, {"efo_term": "BREAST NEOPLASM", "stage": 3}, {"efo_term": "HEAD AND NECK SQUAMOUS CELL CARCINOMA", "stage": 3}, {"efo_term": "GLIOBLASTOMA MULTIFORME", "stage": 2}, {"efo_term": "NASOPHARYNGEAL NEOPLASM", "stage": 2}, {"efo_term": "ENDOMETRIAL NEOPLASM", "stage": 2}, {"efo_term": "HODGKINS LYMPHOMA", "stage": 1}], "max_phase": 4, "name": "AVELUMAB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3833373", "mechanisms": ["Programmed cell death 1 ligand 1 other"], "genes": ["CD274"], "type": "Antibody", "diseases": ["MERKEL CELL SKIN CANCER", "GASTRIC ADENOCARCINOMA", "GLIOBLASTOMA MULTIFORME", "CANCER", "NON-SMALL CELL LUNG CARCINOMA", "NASOPHARYNGEAL NEOPLASM", "NEOPLASM", "OVARIAN CARCINOMA", "BREAST NEOPLASM", "HEAD AND NECK SQUAMOUS CELL CARCINOMA", "HODGKINS LYMPHOMA", "ENDOMETRIAL NEOPLASM"]}, {"indications": [{"efo_term": "CANCER", "stage": 3}, {"efo_term": "COLORECTAL ADENOCARCINOMA", "stage": 3}, {"efo_term": "NON-SMALL CELL LUNG CARCINOMA", "stage": 3}, {"efo_term": "NEOPLASM", "stage": 3}, {"efo_term": "OVARIAN NEOPLASM", "stage": 2}, {"efo_term": "HEREDITARY BREAST AND OVARIAN CANCER SYNDROME", "stage": 2}, {"efo_term": "BLADDER CARCINOMA", "stage": 2}, {"efo_term": "LYMPHOID NEOPLASM", "stage": 1}, {"efo_term": "MYELODYSPLASTIC SYNDROME", "stage": 1}, {"efo_term": "BREAST CARCINOMA", "stage": 1}, {"efo_term": "PROSTATE CARCINOMA", "stage": 1}], "max_phase": 4, "name": "ATEZOLIZUMAB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3707227", "mechanisms": ["Programmed cell death 1 ligand 1 inhibitor"], "genes": ["CD274"], "type": "Antibody", "diseases": ["CANCER", "COLORECTAL ADENOCARCINOMA", "NON-SMALL CELL LUNG CARCINOMA", "LYMPHOID NEOPLASM", "MYELODYSPLASTIC SYNDROME", "BREAST CARCINOMA", "NEOPLASM", "OVARIAN NEOPLASM", "HEREDITARY BREAST AND OVARIAN CANCER SYNDROME", "BLADDER CARCINOMA", "PROSTATE CARCINOMA"]}, {"indications": [{"efo_term": "VIRAL DISEASE", "stage": 4}, {"efo_term": "HIV-1 INFECTION", "stage": 4}, {"efo_term": "HIV INFECTION", "stage": 3}, {"efo_term": "HIV-1 INFECTION", "stage": 3}, {"efo_term": "AIDS", "stage": 3}, {"efo_term": "AIDS DEMENTIA", "stage": 2}, {"efo_term": "RHEUMATOID ARTHRITIS", "stage": 2}, {"efo_term": "ACUTE GRAFT VS. HOST DISEASE", "stage": 2}, {"efo_term": "HYPERTRIGLYCERIDEMIA", "stage": 1}], "max_phase": 4, "name": "MARAVIROC", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201187", "mechanisms": ["C-C chemokine receptor type 5 antagonist"], "genes": ["CCR5"], "type": "Small molecule", "diseases": ["HIV INFECTION", "HIV-1 INFECTION", "AIDS DEMENTIA", "RHEUMATOID ARTHRITIS", "HYPERTRIGLYCERIDEMIA", "AIDS", "ACUTE GRAFT VS. HOST DISEASE", "VIRAL DISEASE"]}, {"indications": [{"efo_term": "CANCER", "stage": 4}, {"efo_term": "COLORECTAL ADENOCARCINOMA", "stage": 4}, {"efo_term": "NEOPLASM", "stage": 4}, {"efo_term": "HEAD AND NECK SQUAMOUS CELL CARCINOMA", "stage": 3}, {"efo_term": "SQUAMOUS CELL CARCINOMA", "stage": 3}, {"efo_term": "CARCINOID SYNDROME", "stage": 2}, {"efo_term": "NON-SMALL CELL LUNG CARCINOMA", "stage": 2}, {"efo_term": "RECTUM CANCER", "stage": 2}, {"efo_term": "PANCREATIC CARCINOMA", "stage": 1}], "max_phase": 4, "name": "PANITUMUMAB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201827", "mechanisms": ["Epidermal growth factor receptor erbB1 inhibitor"], "genes": ["EGFR"], "type": "Antibody", "diseases": ["CANCER", "COLORECTAL ADENOCARCINOMA", "HEAD AND NECK SQUAMOUS CELL CARCINOMA", "SQUAMOUS CELL CARCINOMA", "NEOPLASM", "PANCREATIC CARCINOMA", "CARCINOID SYNDROME", "NON-SMALL CELL LUNG CARCINOMA", "RECTUM CANCER"]}, {"indications": [{"efo_term": "NON-SMALL CELL LUNG CARCINOMA", "stage": 3}, {"efo_term": "HEAD AND NECK SQUAMOUS CELL CARCINOMA", "stage": 2}, {"efo_term": "SQUAMOUS CELL CARCINOMA", "stage": 2}, {"efo_term": "BRAIN NEOPLASM", "stage": 2}, {"efo_term": "CARCINOMA", "stage": 2}, {"efo_term": "GLIOBLASTOMA MULTIFORME", "stage": 2}], "max_phase": 3, "name": "DACOMITINIB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2110732", "mechanisms": ["Epidermal growth factor receptor inhibitor"], "genes": ["EGFR"], "type": "Small molecule", "diseases": ["HEAD AND NECK SQUAMOUS CELL CARCINOMA", "SQUAMOUS CELL CARCINOMA", "NON-SMALL CELL LUNG CARCINOMA", "BRAIN NEOPLASM", "CARCINOMA", "GLIOBLASTOMA MULTIFORME"]}, {"indications": [{"efo_term": "BREAST CARCINOMA", "stage": 4}, {"efo_term": "BREAST NEOPLASM", "stage": 4}, {"efo_term": "BLADDER CARCINOMA", "stage": 2}, {"efo_term": "PROSTATE CARCINOMA", "stage": 2}, {"efo_term": "MALE BREAST CARCINOMA", "stage": 2}], "max_phase": 4, "name": "LAPATINIB DITOSYLATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201179", "mechanisms": ["Epidermal growth factor receptor erbB1 inhibitor"], "genes": ["EGFR"], "type": "Small molecule", "diseases": ["BREAST CARCINOMA", "BLADDER CARCINOMA", "PROSTATE CARCINOMA", "MALE BREAST CARCINOMA", "BREAST NEOPLASM"]}, {"indications": [{"efo_term": "NEOPLASM", "stage": 4}, {"efo_term": "LUNG CARCINOMA", "stage": 2}, {"efo_term": "NON-SMALL CELL LUNG CARCINOMA", "stage": 2}, {"efo_term": "LYMPHOMA", "stage": 2}, {"efo_term": "COLORECTAL CANCER", "stage": 2}], "max_phase": 4, "name": "OSIMERTINIB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3353410", "mechanisms": ["Epidermal growth factor receptor erbB1 inhibitor"], "genes": ["EGFR"], "type": "Small molecule", "diseases": ["LUNG CARCINOMA", "NON-SMALL CELL LUNG CARCINOMA", "LYMPHOMA", "NEOPLASM", "COLORECTAL CANCER"]}, {"indications": [{"efo_term": "NEOPLASM", "stage": 4}, {"efo_term": "CHRONIC MYELOGENOUS LEUKEMIA", "stage": 4}, {"efo_term": "GLIOBLASTOMA MULTIFORME", "stage": 2}, {"efo_term": "BREAST NEOPLASM", "stage": 2}, {"efo_term": "LEUKEMIA", "stage": 2}], "max_phase": 4, "name": "BOSUTINIB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL288441", "mechanisms": ["Tyrosine-protein kinase HCK  inhibitor"], "genes": ["HCK"], "type": "Small molecule", "diseases": ["GLIOBLASTOMA MULTIFORME", "NEOPLASM", "CHRONIC MYELOGENOUS LEUKEMIA", "BREAST NEOPLASM", "LEUKEMIA"]}, {"indications": [{"efo_term": "BREAST NEOPLASM", "stage": 3}, {"efo_term": "BREAST CARCINOMA", "stage": 3}, {"efo_term": "NEOPLASM", "stage": 2}, {"efo_term": "NON-SMALL CELL LUNG CARCINOMA", "stage": 2}], "max_phase": 3, "name": "NERATINIB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL180022", "mechanisms": ["Epidermal growth factor receptor erbB1 inhibitor"], "genes": ["EGFR"], "type": "Small molecule", "diseases": ["BREAST NEOPLASM", "BREAST CARCINOMA", "NEOPLASM", "NON-SMALL CELL LUNG CARCINOMA"]}, {"indications": [{"efo_term": "RHEUMATOID ARTHRITIS", "stage": 2}, {"efo_term": "CUTANEOUS T-CELL LYMPHOMA", "stage": 2}, {"efo_term": "LYMPHOMA", "stage": 2}], "max_phase": 3, "name": "ZANOLIMUMAB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2108063", "mechanisms": ["T-cell surface antigen CD4 other"], "genes": ["CD4"], "type": "Antibody", "diseases": ["RHEUMATOID ARTHRITIS", "CUTANEOUS T-CELL LYMPHOMA", "LYMPHOMA"]}, {"indications": [{"efo_term": "IMMUNE SYSTEM DISEASE", "stage": 4}, {"efo_term": "PROTEINURIA", "stage": 2}, {"efo_term": "TYPE I DIABETES MELLITUS", "stage": 2}], "max_phase": 4, "name": "BELATACEPT", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1742990", "mechanisms": ["T-lymphocyte activation antigen CD86 inhibitor", "T-lymphocyte activation antigen CD80 inhibitor"], "genes": ["CD86", "CD80"], "type": "Protein", "diseases": ["IMMUNE SYSTEM DISEASE", "PROTEINURIA", "TYPE I DIABETES MELLITUS"]}, {"indications": [{"efo_term": "CANCER", "stage": 1}, {"efo_term": "NEOPLASM", "stage": 1}, {"efo_term": "CENTRAL NERVOUS SYSTEM CANCER", "stage": 1}], "max_phase": 1, "name": "AC-480", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1645462", "mechanisms": ["Epidermal growth factor receptor erbB1 inhibitor"], "genes": ["EGFR"], "type": "Small molecule", "diseases": ["CANCER", "NEOPLASM", "CENTRAL NERVOUS SYSTEM CANCER"]}, {"indications": [{"efo_term": "NON-SMALL CELL LUNG CARCINOMA", "stage": 2}, {"efo_term": "COLORECTAL ADENOCARCINOMA", "stage": 1}, {"efo_term": "UPPER AERODIGESTIVE TRACT NEOPLASM", "stage": 1}], "max_phase": 3, "name": "ZALUTUMUMAB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2107861", "mechanisms": ["Epidermal growth factor receptor erbB1 antagonist"], "genes": ["EGFR"], "type": "Antibody", "diseases": ["COLORECTAL ADENOCARCINOMA", "NON-SMALL CELL LUNG CARCINOMA", "UPPER AERODIGESTIVE TRACT NEOPLASM"]}, {"indications": [{"efo_term": "BREAST CARCINOMA", "stage": 2}, {"efo_term": "CANCER", "stage": 1}, {"efo_term": "NEOPLASM", "stage": 1}], "max_phase": 2, "name": "Poziotinib", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545154", "mechanisms": ["Epidermal growth factor receptor inhibitor"], "genes": ["EGFR"], "type": "Small molecule", "diseases": ["BREAST CARCINOMA", "CANCER", "NEOPLASM"]}, {"indications": [{"efo_term": "LYMPHOMA", "stage": 2}, {"efo_term": "NON-HODGKINS LYMPHOMA", "stage": 1}], "max_phase": 3, "name": "GALIXIMAB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2109191", "mechanisms": ["T-lymphocyte activation antigen CD80 inhibitor"], "genes": ["CD80"], "type": "Antibody", "diseases": ["LYMPHOMA", "NON-HODGKINS LYMPHOMA"]}, {"indications": [{"efo_term": "HIV-1 INFECTION", "stage": 2}, {"efo_term": "SCLEROSING CHOLANGITIS", "stage": 2}], "max_phase": 2, "name": "CENICRIVIROC", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2110727", "mechanisms": ["C-C chemokine receptor type 5 antagonist"], "genes": ["CCR5"], "type": "Small molecule", "diseases": ["HIV-1 INFECTION", "SCLEROSING CHOLANGITIS"]}, {"indications": [{"efo_term": "DIABETIC NEPHROPATHY", "stage": 2}, {"efo_term": "RENAL INSUFFICIENCY", "stage": 1}], "max_phase": 2, "name": "PF-04634817", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545032", "mechanisms": ["C-C chemokine receptor type 5 antagonist"], "genes": ["CCR5"], "type": "Small molecule", "diseases": ["DIABETIC NEPHROPATHY", "RENAL INSUFFICIENCY"]}, {"indications": [{"efo_term": "GLIOBLASTOMA MULTIFORME", "stage": 1}, {"efo_term": "CANCER", "stage": 1}], "max_phase": 2, "name": "AEE-788", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL587723", "mechanisms": ["Epidermal growth factor receptor erbB1 inhibitor"], "genes": ["EGFR"], "type": "Small molecule", "diseases": ["GLIOBLASTOMA MULTIFORME", "CANCER"]}, {"indications": [{"efo_term": "NON-SMALL CELL LUNG CARCINOMA", "stage": 4}, {"efo_term": "NEOPLASM", "stage": 4}], "max_phase": 4, "name": "NECITUMUMAB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1743047", "mechanisms": ["Epidermal growth factor receptor erbB1 inhibitor"], "genes": ["EGFR"], "type": "Antibody", "diseases": ["NON-SMALL CELL LUNG CARCINOMA", "NEOPLASM"]}, {"indications": [{"efo_term": "NON-SMALL CELL LUNG CARCINOMA", "stage": 2}, {"efo_term": "BREAST CARCINOMA", "stage": 1}], "max_phase": 2, "name": "Pyrotinib", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3544956", "mechanisms": ["Epidermal growth factor receptor erbB1 inhibitor"], "genes": ["EGFR"], "type": "Small molecule", "diseases": ["BREAST CARCINOMA", "NON-SMALL CELL LUNG CARCINOMA"]}, {"indications": [{"efo_term": "NEOPLASM", "stage": 1}, {"efo_term": "CANCER", "stage": 1}], "max_phase": 1, "name": "MP-412", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545002", "mechanisms": ["Epidermal growth factor receptor erbB1 inhibitor"], "genes": ["EGFR"], "type": "Small molecule", "diseases": ["NEOPLASM", "CANCER"]}, {"indications": [{"efo_term": "NEOPLASM", "stage": 4}, {"efo_term": "NON-SMALL CELL LUNG CARCINOMA", "stage": 3}], "max_phase": 3, "name": "ROCILETINIB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545308", "mechanisms": ["Epidermal growth factor receptor erbB1 inhibitor"], "genes": ["EGFR"], "type": "Small molecule", "diseases": ["NON-SMALL CELL LUNG CARCINOMA", "NEOPLASM"]}, {"indications": [{"efo_term": "NON-SMALL CELL LUNG CARCINOMA", "stage": 2}, {"efo_term": "CANCER", "stage": 1}], "max_phase": 2, "name": "BMS-690514", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545396", "mechanisms": ["Epidermal growth factor receptor erbB1 inhibitor"], "genes": ["EGFR"], "type": "Small molecule", "diseases": ["CANCER", "NON-SMALL CELL LUNG CARCINOMA"]}, {"indications": [{"efo_term": "CANCER", "stage": 2}, {"efo_term": "NEOPLASM", "stage": 2}], "max_phase": 2, "name": "ILORASERTIB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1980297", "mechanisms": ["SRC inhibitor"], "genes": ["HCK"], "type": "Small molecule", "diseases": ["CANCER", "NEOPLASM"]}, {"indications": [{"efo_term": "HIV INFECTION", "stage": 3}], "max_phase": 3, "name": "IBALIZUMAB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1743029", "mechanisms": ["T-cell surface antigen CD4 inhibitor"], "genes": ["CD4"], "type": "Antibody", "diseases": ["HIV INFECTION"]}, {"indications": [{"efo_term": "RHEUMATOID ARTHRITIS", "stage": 2}], "max_phase": 2, "name": "TREGALIZUMAB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1743083", "mechanisms": ["T-cell surface antigen CD4 agonist"], "genes": ["CD4"], "type": "Antibody", "diseases": ["RHEUMATOID ARTHRITIS"]}, {"indications": [{"efo_term": "HIV INFECTION", "stage": 2}], "max_phase": 2, "name": "INCB-9471", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1688243", "mechanisms": ["C-C chemokine receptor type 5 antagonist"], "genes": ["CCR5"], "type": "Small molecule", "diseases": ["HIV INFECTION"]}, {"indications": [{"efo_term": "RHEUMATOID ARTHRITIS", "stage": 2}], "max_phase": 2, "name": "AZD5672", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1951914", "mechanisms": ["C-C chemokine receptor type 5 antagonist"], "genes": ["CCR5"], "type": "Small molecule", "diseases": ["RHEUMATOID ARTHRITIS"]}, {"indications": [{"efo_term": "HIV INFECTION", "stage": 2}], "max_phase": 3, "name": "VICRIVIROC MALEATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2107384", "mechanisms": ["C-C chemokine receptor type 5 antagonist"], "genes": ["CCR5"], "type": "Small molecule", "diseases": ["HIV INFECTION"]}, {"indications": [{"efo_term": "HIV INFECTION", "stage": 2}], "max_phase": 2, "name": "PRO-140", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2109343", "mechanisms": ["C-C chemokine receptor type 5 antagonist"], "genes": ["CCR5"], "type": "Antibody", "diseases": ["HIV INFECTION"]}, {"indications": [{"efo_term": "CANCER", "stage": 1}], "max_phase": 1, "name": "CUDC-101", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL598797", "mechanisms": ["Epidermal growth factor receptor erbB1 inhibitor"], "genes": ["EGFR"], "type": "Small molecule", "diseases": ["CANCER"]}, {"indications": [{"efo_term": "CANCER", "stage": 1}], "max_phase": 1, "name": "TAK-285", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1614725", "mechanisms": ["Epidermal growth factor receptor erbB1 inhibitor"], "genes": ["EGFR"], "type": "Small molecule", "diseases": ["CANCER"]}, {"indications": [{"efo_term": "NEOPLASM", "stage": 1}], "max_phase": 1, "name": "CEP-32496", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2029988", "mechanisms": ["Epidermal growth factor receptor erbB1 inhibitor"], "genes": ["EGFR"], "type": "Small molecule", "diseases": ["NEOPLASM"]}, {"indications": [{"efo_term": "CHOLANGIOCARCINOMA", "stage": 2}], "max_phase": 2, "name": "VARLITINIB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2103842", "mechanisms": ["Epidermal growth factor receptor erbB1 inhibitor"], "genes": ["EGFR"], "type": "Small molecule", "diseases": ["CHOLANGIOCARCINOMA"]}, {"indications": [{"efo_term": "NON-SMALL CELL LUNG CARCINOMA", "stage": 4}], "max_phase": 4, "name": "AFATINIB DIMALEATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2105712", "mechanisms": ["Epidermal growth factor receptor erbB1 inhibitor"], "genes": ["EGFR"], "type": "Small molecule", "diseases": ["NON-SMALL CELL LUNG CARCINOMA"]}, {"indications": [{"efo_term": "CENTRAL NERVOUS SYSTEM CANCER", "stage": 2}], "max_phase": 2, "name": "mAb-425", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2109390", "mechanisms": ["Epidermal growth factor receptor erbB1 inhibitor"], "genes": ["EGFR"], "type": "Antibody", "diseases": ["CENTRAL NERVOUS SYSTEM CANCER"]}, {"indications": [{"efo_term": "GLIOBLASTOMA MULTIFORME", "stage": 2}], "max_phase": 2, "name": "TESEVATINIB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3544983", "mechanisms": ["Epidermal growth factor receptor erbB1 inhibitor"], "genes": ["EGFR"], "type": "Small molecule", "diseases": ["GLIOBLASTOMA MULTIFORME"]}, {"indications": [{"efo_term": "NEOPLASM", "stage": 1}], "max_phase": 1, "name": "Epitinib", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545121", "mechanisms": ["Epidermal growth factor receptor erbB1 inhibitor"], "genes": ["EGFR"], "type": "Small molecule", "diseases": ["NEOPLASM"]}, {"indications": [{"efo_term": "CANCER", "stage": 1}], "max_phase": 1, "name": "Theliatinib", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545180", "mechanisms": ["Epidermal growth factor receptor erbB1 inhibitor"], "genes": ["EGFR"], "type": "Small molecule", "diseases": ["CANCER"]}, {"indications": [{"efo_term": "NON-SMALL CELL LUNG CARCINOMA", "stage": 1}], "max_phase": 2, "name": "EGF816", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545234", "mechanisms": ["Epidermal growth factor receptor erbB1 inhibitor"], "genes": ["EGFR"], "type": "Small molecule", "diseases": ["NON-SMALL CELL LUNG CARCINOMA"]}, {"indications": [{"efo_term": "NON-SMALL CELL LUNG CARCINOMA", "stage": 3}], "max_phase": 3, "name": "BRIGATINIB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545311", "mechanisms": ["Epidermal growth factor receptor erbB1 inhibitor"], "genes": ["EGFR"], "type": "Small molecule", "diseases": ["NON-SMALL CELL LUNG CARCINOMA"]}, {"indications": [{"efo_term": "NON-SMALL CELL LUNG CARCINOMA", "stage": 2}], "max_phase": 2, "name": "HM-61713", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545430", "mechanisms": ["Epidermal growth factor receptor erbB1 inhibitor"], "genes": ["EGFR"], "type": "Small molecule", "diseases": ["NON-SMALL CELL LUNG CARCINOMA"]}, {"indications": [{"efo_term": "NON-SMALL CELL LUNG CARCINOMA", "stage": 4}], "max_phase": 4, "name": "OSIMERTINIB MESYLATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545063", "mechanisms": ["Epidermal growth factor receptor inhibitor"], "genes": ["EGFR"], "type": "Small molecule", "diseases": ["NON-SMALL CELL LUNG CARCINOMA"]}, {"indications": [{"efo_term": "LYMPHOMA", "stage": 1}], "max_phase": 1, "name": "XL-228", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545085", "mechanisms": ["SRC inhibitor"], "genes": ["HCK"], "type": "Small molecule", "diseases": ["LYMPHOMA"]}, {"indications": [], "max_phase": 2, "name": "CLENOLIXIMAB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2108187", "mechanisms": ["T-cell surface antigen CD4 inhibitor"], "genes": ["CD4"], "type": "Antibody", "diseases": []}, {"indications": [], "max_phase": 1, "name": "CEDELIZUMAB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2108266", "mechanisms": ["T-cell surface antigen CD4 inhibitor"], "genes": ["CD4"], "type": "Antibody", "diseases": []}, {"indications": [], "max_phase": 2, "name": "PRILIXIMAB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2108475", "mechanisms": ["T-cell surface antigen CD4 negative modulator"], "genes": ["CD4"], "type": "Antibody", "diseases": []}, {"indications": [], "max_phase": 2, "name": "KELIXIMAB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2108489", "mechanisms": ["T-cell surface antigen CD4 negative modulator"], "genes": ["CD4"], "type": "Antibody", "diseases": []}, {"indications": [], "max_phase": 2, "name": "TRX-1", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2109474", "mechanisms": ["T-cell surface antigen CD4 inhibitor"], "genes": ["CD4"], "type": "Antibody", "diseases": []}, {"indications": [], "max_phase": 3, "name": "APLAVIROC HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1668019", "mechanisms": ["C-C chemokine receptor type 5 antagonist"], "genes": ["CCR5"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "NI-0801", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2109379", "mechanisms": ["C-X-C motif chemokine 10 inhibitor"], "genes": ["CXCL10"], "type": "Antibody", "diseases": []}, {"indications": [], "max_phase": 1, "name": "AZD-4769", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL422872", "mechanisms": ["Epidermal growth factor receptor erbB1 inhibitor"], "genes": ["EGFR"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 1, "name": "FALNIDAMOL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL258940", "mechanisms": ["Epidermal growth factor receptor erbB1 inhibitor"], "genes": ["EGFR"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 3, "name": "CANERTINIB DIHYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL545315", "mechanisms": ["Epidermal growth factor receptor erbB1 inhibitor"], "genes": ["EGFR"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "PELITINIB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL607707", "mechanisms": ["Epidermal growth factor receptor erbB1 inhibitor"], "genes": ["EGFR"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 1, "name": "PKI-166", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1963502", "mechanisms": ["Epidermal growth factor receptor erbB1 inhibitor"], "genes": ["EGFR"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 3, "name": "DACOMITINIB HYDRATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2105719", "mechanisms": ["Epidermal growth factor receptor erbB1 inhibitor"], "genes": ["EGFR"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "MATUZUMAB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2108038", "mechanisms": ["Epidermal growth factor receptor erbB1 inhibitor"], "genes": ["EGFR"], "type": "Antibody", "diseases": []}, {"indications": [], "max_phase": 2, "name": "MDX-447", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2109391", "mechanisms": ["Epidermal growth factor receptor erbB1 other"], "genes": ["EGFR"], "type": "Antibody", "diseases": []}, {"indications": [], "max_phase": 2, "name": "RG-7160", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2109393", "mechanisms": ["Epidermal growth factor receptor erbB1 antagonist"], "genes": ["EGFR"], "type": "Antibody", "diseases": []}, {"indications": [], "max_phase": 2, "name": "SAPITINIB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2408045", "mechanisms": ["Epidermal growth factor receptor erbB1 inhibitor"], "genes": ["EGFR"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 1, "name": "Puquitinib", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545088", "mechanisms": ["Epidermal growth factor receptor erbB1 inhibitor"], "genes": ["EGFR"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 1, "name": "JNJ-26483327", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545133", "mechanisms": ["Epidermal growth factor receptor erbB1 inhibitor"], "genes": ["EGFR"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 1, "name": "PD-0166285", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545196", "mechanisms": ["Epidermal growth factor receptor erbB1 inhibitor"], "genes": ["EGFR"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 1, "name": "S-222611", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545200", "mechanisms": ["Epidermal growth factor receptor erbB1 inhibitor"], "genes": ["EGFR"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 3, "name": "Simotinib", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545235", "mechanisms": ["Epidermal growth factor receptor erbB1 inhibitor"], "genes": ["EGFR"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 1, "name": "Allitinib", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545244", "mechanisms": ["Epidermal growth factor receptor erbB1 inhibitor"], "genes": ["EGFR"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "ENMD-981693", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL52885", "mechanisms": ["SRC inhibitor"], "genes": ["HCK"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "TG100-801", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL403989", "mechanisms": ["SRC inhibitor"], "genes": ["HCK"], "type": "Small molecule", "diseases": []}], "heat": 0.09414712856415218, "nodes": [{"assoc": 0.03762, "id": "ENSG00000006210", "label": "CX3CL1"}, {"assoc": 0.0164725, "id": "ENSG00000006606", "label": "CCL26"}, {"assoc": 0.0541767767183, "id": "ENSG00000010610", "label": "CD4"}, {"assoc": 0.733903416667, "id": "ENSG00000114013", "label": "CD86"}, {"assoc": 0.73333675, "id": "ENSG00000121594", "label": "CD80"}, {"assoc": 0.017512, "id": "ENSG00000151882", "label": "CCL28"}, {"assoc": 0.04559025, "id": "ENSG00000160791", "label": "CCR5"}, {"assoc": 0.06452, "id": "ENSG00000163599", "label": "CTLA4"}, {"assoc": 0.0297, "id": "ENSG00000168329", "label": "CX3CR1"}, {"assoc": 0.01404, "id": "ENSG00000169245", "label": "CXCL10"}, {"assoc": 0.0581452358122, "id": "ENSG00000178562", "label": "CD28"}, {"assoc": 0.026686, "id": "ENSG00000183625", "label": "CCR3"}, {"assoc": 0.0156, "id": "ENSG00000188389", "label": "PDCD1"}, {"assoc": 0.318081027778, "id": "ENSG00000223865", "label": "HLA-DPB1"}, {"assoc": 0, "id": "ENSG00000231389", "label": "HLA-DPA1"}, {"assoc": 0, "id": "ENSG00000185338", "label": "SOCS1"}, {"assoc": 0, "id": "ENSG00000146648", "label": "EGFR"}, {"assoc": 0, "id": "ENSG00000101336", "label": "HCK"}, {"assoc": 0, "id": "ENSG00000111679", "label": "PTPN6"}, {"assoc": 0, "id": "ENSG00000120217", "label": "CD274"}, {"assoc": 0, "id": "ENSG00000196092", "label": "PAX5"}, {"assoc": 0, "id": "ENSG00000134954", "label": "ETS1"}, {"assoc": 0, "id": "ENSG00000141510", "label": "TP53"}], "size": 23}, {"diseases": ["IDIOPATHIC PULMONARY FIBROSIS", "FOCAL SEGMENTAL GLOMERULOSCLEROSIS", "NON-SMALL CELL LUNG CARCINOMA", "BREAST CARCINOMA", "DIFFUSE SCLERODERMA", "BRAIN NEOPLASM", "DIABETIC NEPHROPATHY", "GOUT", "CHRONIC CHILDHOOD ARTHRITIS", "FAMILIAL MEDITERRANEAN FEVER", "TYPE I DIABETES MELLITUS", "IMMUNE SYSTEM DISEASE", "CRYOPYRIN-ASSOCIATED PERIODIC SYNDROME", "FAMILIAL COLD URTICARIA", "MUCKLE-WELLS SYNDROME", "MEVALONATE KINASE DEFICIENCY", "FEVER", "URTICARIA", "PYODERMA", "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "ATHEROSCLEROSIS", "RHEUMATOID ARTHRITIS", "ABDOMINAL AORTIC ANEURYSM", "PERIPHERAL ARTERIAL DISEASE", "OSTEOARTHRITIS", "ATRIAL FIBRILLATION", "DIABETES MELLITUS", "CINCA SYNDROME", "DIABETIC RETINOPATHY", "PULMONARY SARCOIDOSIS", "DRY EYE SYNDROME", "SCLERITIS", "TYPE II DIABETES MELLITUS", "BEHCET'S SYNDROME", "ACNE", "UVEITIS", "LIVER DISEASE", "SICKLE CELL ANEMIA", "PSORIASIS", "INTERSTITIAL LUNG DISEASE", "MELANOMA", "CUTANEOUS T-CELL LYMPHOMA", "CANCER", "DIFFUSE LARGE B-CELL LYMPHOMA", "ULCERATIVE COLITIS", "POSTERIOR UVEITIS", "ACUTE MYELOID LEUKEMIA", "LEUKEMIA", "NEOPLASM", "RECTUM CANCER"], "links": [{"source": "ENSG00000005381", "target": "ENSG00000047457"}, {"source": "ENSG00000012223", "target": "ENSG00000047457"}, {"source": "ENSG00000012223", "type": "directed", "target": "ENSG00000170458"}, {"source": "ENSG00000092969", "type": "inhibitory", "target": "ENSG00000105329", "reverse": "rev-inhibitory"}, {"source": "ENSG00000105329", "type": "inhibitory", "target": "ENSG00000137462"}, {"source": "ENSG00000125538", "type": "directed", "target": "ENSG00000189403"}, {"source": "ENSG00000137462", "target": "ENSG00000170458", "reverse": "rev-stimulatory"}, {"source": "ENSG00000170458", "type": "directed", "target": "ENSG00000239732"}, {"source": "ENSG00000189403", "type": "inhibitory", "target": "ENSG00000239732", "reverse": "rev-directed"}, {"source": "ENSG00000188404", "type": "manual", "target": "ENSG00000171195"}, {"source": "ENSG00000171195", "type": "manual", "target": "ENSG00000012223"}, {"source": "ENSG00000188404", "type": "manual", "target": "ENSG00000000971"}, {"source": "ENSG00000000971", "type": "manual", "target": "ENSG00000169896"}, {"source": "ENSG00000169896", "type": "manual", "target": "ENSG00000170458"}, {"source": "ENSG00000188404", "type": "manual", "target": "ENSG00000154229"}, {"source": "ENSG00000154229", "type": "manual", "target": "ENSG00000135218"}, {"source": "ENSG00000135218", "type": "manual", "target": "ENSG00000170458"}, {"source": "ENSG00000188404", "type": "manual", "target": "ENSG00000177885"}, {"source": "ENSG00000177885", "type": "manual", "target": "ENSG00000163513"}, {"source": "ENSG00000163513", "type": "manual", "target": "ENSG00000092969"}, {"source": "ENSG00000188404", "type": "manual", "target": "ENSG00000065675"}, {"source": "ENSG00000065675", "type": "manual", "target": "ENSG00000067606"}, {"source": "ENSG00000067606", "type": "manual", "target": "ENSG00000137462"}, {"source": "ENSG00000188404", "type": "manual", "target": "ENSG00000163558"}, {"source": "ENSG00000163558", "type": "manual", "target": "ENSG00000067606"}, {"source": "ENSG00000188404", "type": "manual", "target": "ENSG00000038427"}, {"source": "ENSG00000038427", "type": "manual", "target": "ENSG00000166147"}, {"source": "ENSG00000166147", "type": "manual", "target": "ENSG00000105329"}], "drugs": [{"indications": [{"efo_term": "CHRONIC CHILDHOOD ARTHRITIS", "stage": 4}, {"efo_term": "MEVALONATE KINASE DEFICIENCY", "stage": 4}, {"efo_term": "FAMILIAL MEDITERRANEAN FEVER", "stage": 4}, {"efo_term": "IMMUNE SYSTEM DISEASE", "stage": 4}, {"efo_term": "CINCA SYNDROME", "stage": 4}, {"efo_term": "CRYOPYRIN-ASSOCIATED PERIODIC SYNDROME", "stage": 4}, {"efo_term": "GOUT", "stage": 3}, {"efo_term": "FEVER", "stage": 3}, {"efo_term": "ATHEROSCLEROSIS", "stage": 3}, {"efo_term": "URTICARIA", "stage": 2}, {"efo_term": "PYODERMA", "stage": 2}, {"efo_term": "RHEUMATOID ARTHRITIS", "stage": 2}, {"efo_term": "ABDOMINAL AORTIC ANEURYSM", "stage": 2}, {"efo_term": "PERIPHERAL ARTERIAL DISEASE", "stage": 2}, {"efo_term": "OSTEOARTHRITIS", "stage": 2}, {"efo_term": "ATRIAL FIBRILLATION", "stage": 2}, {"efo_term": "DIABETES MELLITUS", "stage": 2}, {"efo_term": "PULMONARY SARCOIDOSIS", "stage": 2}, {"efo_term": "TYPE I DIABETES MELLITUS", "stage": 2}, {"efo_term": "DRY EYE SYNDROME", "stage": 2}, {"efo_term": "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "stage": 1}, {"efo_term": "DIABETIC RETINOPATHY", "stage": 1}], "max_phase": 4, "name": "CANAKINUMAB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201834", "mechanisms": ["Interleukin-1 beta inhibitor"], "genes": ["IL1B"], "type": "Antibody", "diseases": ["CHRONIC CHILDHOOD ARTHRITIS", "MEVALONATE KINASE DEFICIENCY", "GOUT", "FEVER", "URTICARIA", "FAMILIAL MEDITERRANEAN FEVER", "PYODERMA", "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "ATHEROSCLEROSIS", "RHEUMATOID ARTHRITIS", "IMMUNE SYSTEM DISEASE", "ABDOMINAL AORTIC ANEURYSM", "PERIPHERAL ARTERIAL DISEASE", "OSTEOARTHRITIS", "ATRIAL FIBRILLATION", "DIABETES MELLITUS", "CINCA SYNDROME", "CRYOPYRIN-ASSOCIATED PERIODIC SYNDROME", "DIABETIC RETINOPATHY", "PULMONARY SARCOIDOSIS", "TYPE I DIABETES MELLITUS", "DRY EYE SYNDROME"]}, {"indications": [{"efo_term": "BEHCET'S SYNDROME", "stage": 3}, {"efo_term": "PYODERMA", "stage": 3}, {"efo_term": "UVEITIS", "stage": 3}, {"efo_term": "TYPE I DIABETES MELLITUS", "stage": 2}, {"efo_term": "OSTEOARTHRITIS", "stage": 2}, {"efo_term": "TYPE II DIABETES MELLITUS", "stage": 2}, {"efo_term": "ACNE", "stage": 2}, {"efo_term": "RHEUMATOID ARTHRITIS", "stage": 2}, {"efo_term": "SCLERITIS", "stage": 1}], "max_phase": 3, "name": "GEVOKIZUMAB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1743026", "mechanisms": ["Interleukin-1 beta negative allosteric modulator"], "genes": ["IL1B"], "type": "Antibody", "diseases": ["TYPE I DIABETES MELLITUS", "OSTEOARTHRITIS", "SCLERITIS", "TYPE II DIABETES MELLITUS", "BEHCET'S SYNDROME", "ACNE", "PYODERMA", "RHEUMATOID ARTHRITIS", "UVEITIS"]}, {"indications": [{"efo_term": "IMMUNE SYSTEM DISEASE", "stage": 4}, {"efo_term": "CRYOPYRIN-ASSOCIATED PERIODIC SYNDROME", "stage": 4}, {"efo_term": "FAMILIAL COLD URTICARIA", "stage": 4}, {"efo_term": "MUCKLE-WELLS SYNDROME", "stage": 4}, {"efo_term": "GOUT", "stage": 3}, {"efo_term": "CHRONIC CHILDHOOD ARTHRITIS", "stage": 2}, {"efo_term": "FAMILIAL MEDITERRANEAN FEVER", "stage": 2}, {"efo_term": "TYPE I DIABETES MELLITUS", "stage": 1}], "max_phase": 4, "name": "RILONACEPT", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201830", "mechanisms": ["Interleukin-1 beta inhibitor"], "genes": ["IL1B"], "type": "Protein", "diseases": ["GOUT", "CHRONIC CHILDHOOD ARTHRITIS", "FAMILIAL MEDITERRANEAN FEVER", "TYPE I DIABETES MELLITUS", "IMMUNE SYSTEM DISEASE", "CRYOPYRIN-ASSOCIATED PERIODIC SYNDROME", "FAMILIAL COLD URTICARIA", "MUCKLE-WELLS SYNDROME"]}, {"indications": [{"efo_term": "FOCAL SEGMENTAL GLOMERULOSCLEROSIS", "stage": 2}, {"efo_term": "BREAST CARCINOMA", "stage": 2}, {"efo_term": "BRAIN NEOPLASM", "stage": 2}, {"efo_term": "IDIOPATHIC PULMONARY FIBROSIS", "stage": 1}, {"efo_term": "NON-SMALL CELL LUNG CARCINOMA", "stage": 1}, {"efo_term": "DIFFUSE SCLERODERMA", "stage": 1}], "max_phase": 2, "name": "FRESOLIMUMAB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1743022", "mechanisms": ["Transforming growth factor beta-2 inhibitor", "Transforming growth factor beta-1 inhibitor"], "genes": ["TGFB2", "TGFB1"], "type": "Antibody", "diseases": ["IDIOPATHIC PULMONARY FIBROSIS", "FOCAL SEGMENTAL GLOMERULOSCLEROSIS", "NON-SMALL CELL LUNG CARCINOMA", "BREAST CARCINOMA", "DIFFUSE SCLERODERMA", "BRAIN NEOPLASM"]}, {"indications": [{"efo_term": "NEOPLASM", "stage": 4}, {"efo_term": "ACUTE MYELOID LEUKEMIA", "stage": 2}, {"efo_term": "LEUKEMIA", "stage": 2}, {"efo_term": "LIVER DISEASE", "stage": 1}, {"efo_term": "RECTUM CANCER", "stage": 1}], "max_phase": 3, "name": "MIDOSTAURIN", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL608533", "mechanisms": ["Protein kinase C (PKC) inhibitor"], "genes": ["PRKCA", "PRKCQ", "PRKCZ", "PRKCI"], "type": "Small molecule", "diseases": ["ACUTE MYELOID LEUKEMIA", "LEUKEMIA", "LIVER DISEASE", "NEOPLASM", "RECTUM CANCER"]}, {"indications": [{"efo_term": "ULCERATIVE COLITIS", "stage": 2}, {"efo_term": "POSTERIOR UVEITIS", "stage": 2}, {"efo_term": "PSORIASIS", "stage": 2}, {"efo_term": "DIFFUSE LARGE B-CELL LYMPHOMA", "stage": 1}], "max_phase": 2, "name": "SOTRASTAURIN", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL565612", "mechanisms": ["Protein kinase C (PKC) inhibitor"], "genes": ["PRKCA", "PRKCQ", "PRKCZ", "PRKCI"], "type": "Small molecule", "diseases": ["DIFFUSE LARGE B-CELL LYMPHOMA", "ULCERATIVE COLITIS", "POSTERIOR UVEITIS", "PSORIASIS"]}, {"indications": [{"efo_term": "SICKLE CELL ANEMIA", "stage": 3}, {"efo_term": "LIVER DISEASE", "stage": 1}], "max_phase": 3, "name": "RIVIPANSEL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3707446", "mechanisms": ["Leukocyte adhesion molecule-1 antagonist"], "genes": ["SELL"], "type": "Small molecule", "diseases": ["LIVER DISEASE", "SICKLE CELL ANEMIA"]}, {"indications": [{"efo_term": "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "stage": 2}, {"efo_term": "PSORIASIS", "stage": 2}], "max_phase": 2, "name": "BIMOSIAMOSE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1215923", "mechanisms": ["Selectin inhibitor"], "genes": ["SELL"], "type": "Small molecule", "diseases": ["CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "PSORIASIS"]}, {"indications": [{"efo_term": "MELANOMA", "stage": 2}, {"efo_term": "CUTANEOUS T-CELL LYMPHOMA", "stage": 1}], "max_phase": 3, "name": "AGATOLIMOD SODIUM", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2103793", "mechanisms": ["Toll-like receptor 9 agonist"], "genes": ["TLR9"], "type": "Oligonucleotide", "diseases": ["MELANOMA", "CUTANEOUS T-CELL LYMPHOMA"]}, {"indications": [{"efo_term": "DIABETIC NEPHROPATHY", "stage": 2}], "max_phase": 2, "name": "LY-2382770", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2109585", "mechanisms": ["Transforming growth factor beta-1 inhibitor"], "genes": ["TGFB1"], "type": "Antibody", "diseases": ["DIABETIC NEPHROPATHY"]}, {"indications": [{"efo_term": "INTERSTITIAL LUNG DISEASE", "stage": 2}], "max_phase": 4, "name": "HYDROXYCHLOROQUINE SULFATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1690", "mechanisms": ["Toll-like receptor 9 antagonist"], "genes": ["TLR9"], "type": "Small molecule", "diseases": ["INTERSTITIAL LUNG DISEASE"]}, {"indications": [{"efo_term": "CANCER", "stage": 1}], "max_phase": 1, "name": "GSK-690693", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL494089", "mechanisms": ["Protein kinase C (PKC) inhibitor"], "genes": ["PRKCA", "PRKCQ", "PRKCZ", "PRKCI"], "type": "Small molecule", "diseases": ["CANCER"]}, {"indications": [{"efo_term": "MELANOMA", "stage": 2}], "max_phase": 2, "name": "(7S)-HYDROXYL-STAUROSPORINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL574737", "mechanisms": ["Protein kinase C (PKC) inhibitor"], "genes": ["PRKCA", "PRKCQ", "PRKCZ", "PRKCI"], "type": "Small molecule", "diseases": ["MELANOMA"]}, {"indications": [], "max_phase": 3, "name": "LERDELIMUMAB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2108967", "mechanisms": ["Transforming growth factor beta-2 inhibitor"], "genes": ["TGFB2"], "type": "Antibody", "diseases": []}, {"indications": [], "max_phase": 2, "name": "METELIMUMAB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2108431", "mechanisms": ["Transforming growth factor beta-1 inhibitor"], "genes": ["TGFB1"], "type": "Antibody", "diseases": []}, {"indications": [], "max_phase": 2, "name": "IC14", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2109330", "mechanisms": ["Monocyte differentiation antigen CD14 inhibitor"], "genes": ["CD14"], "type": "Antibody", "diseases": []}, {"indications": [], "max_phase": 2, "name": "ASELIZUMAB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2108575", "mechanisms": ["Leukocyte adhesion molecule-1 inhibitor"], "genes": ["SELL"], "type": "Antibody", "diseases": []}, {"indications": [], "max_phase": 2, "name": "ROVELIZUMAB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2109224", "mechanisms": ["Integrin alpha-M/beta-2 antagonist"], "genes": ["ITGAM"], "type": "Antibody", "diseases": []}, {"indications": [], "max_phase": 1, "name": "CEP-2563", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545332", "mechanisms": ["Protein kinase C (PKC) inhibitor"], "genes": ["PRKCA", "PRKCQ", "PRKCZ", "PRKCI"], "type": "Small molecule", "diseases": []}], "heat": 0.014949970280386958, "nodes": [{"assoc": 0.06247772756, "id": "ENSG00000005381", "label": "MPO"}, {"assoc": 0.031284, "id": "ENSG00000012223", "label": "LTF"}, {"assoc": 0.020988, "id": "ENSG00000047457", "label": "CP"}, {"assoc": 0.014256, "id": "ENSG00000092969", "label": "TGFB2"}, {"assoc": 0.025542, "id": "ENSG00000105329", "label": "TGFB1"}, {"assoc": 0.0376315888889, "id": "ENSG00000125538", "label": "IL1B"}, {"assoc": 0.0423085, "id": "ENSG00000137462", "label": "TLR2"}, {"assoc": 0.017424, "id": "ENSG00000170458", "label": "CD14"}, {"assoc": 0.0296, "id": "ENSG00000188404", "label": "SELL"}, {"assoc": 0.021034, "id": "ENSG00000189403", "label": "HMGB1"}, {"assoc": 0.0413035, "id": "ENSG00000239732", "label": "TLR9"}, {"assoc": 0, "id": "ENSG00000171195", "label": "MUC7"}, {"assoc": 0, "id": "ENSG00000000971", "label": "CFH"}, {"assoc": 0, "id": "ENSG00000169896", "label": "ITGAM"}, {"assoc": 0, "id": "ENSG00000154229", "label": "PRKCA"}, {"assoc": 0, "id": "ENSG00000135218", "label": "CD36"}, {"assoc": 0, "id": "ENSG00000177885", "label": "GRB2"}, {"assoc": 0, "id": "ENSG00000163513", "label": "TGFBR2"}, {"assoc": 0, "id": "ENSG00000065675", "label": "PRKCQ"}, {"assoc": 0, "id": "ENSG00000067606", "label": "PRKCZ"}, {"assoc": 0, "id": "ENSG00000163558", "label": "PRKCI"}, {"assoc": 0, "id": "ENSG00000038427", "label": "VCAN"}, {"assoc": 0, "id": "ENSG00000166147", "label": "FBN1"}], "size": 23}, {"diseases": ["MULTIPLE MYELOMA", "MELANOMA", "OVARIAN CARCINOMA", "PANCREATIC CARCINOMA", "NEOPLASM", "MALE BREAST CARCINOMA", "LYMPHOMA", "T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA", "ACUTE GRAFT VS. HOST DISEASE", "UNSPECIFIED PERIPHERAL T-CELL LYMPHOMA", "ULCERATIVE COLITIS", "IMMUNE SYSTEM DISEASE", "CHRONIC KIDNEY DISEASE", "ISCHEMIA REPERFUSION INJURY", "ACUTE MYELOID LEUKEMIA", "UVEITIS", "LEUKEMIA", "METASTATIC MELANOMA", "RENAL CARCINOMA", "TYPE I DIABETES MELLITUS", "CANCER", "HIV INFECTION", "RENAL CELL CARCINOMA", "AMYOTROPHIC LATERAL SCLEROSIS", "CUTANEOUS MELANOMA", "NEUROBLASTOMA", "BREAST CARCINOMA", "CLEAR CELL RENAL CARCINOMA", "NEPHROTIC SYNDROME", "LIVER DISEASE", "ALOPECIA AREATA", "PSORIASIS", "RELAPSING-REMITTING MULTIPLE SCLEROSIS", "MULTIPLE SCLEROSIS", "TUBERCULOSIS", "CELIAC DISEASE"], "links": [{"source": "ENSG00000100385", "type": "inhibitory", "target": "ENSG00000109471", "reverse": "rev-stimulatory"}, {"source": "ENSG00000100385", "type": "stimulatory", "target": "ENSG00000134460", "reverse": "rev-directed"}, {"source": "ENSG00000100385", "type": "inhibitory", "target": "ENSG00000147168", "reverse": "rev-inhibitory"}, {"source": "ENSG00000100385", "type": "directed", "target": "ENSG00000164136", "reverse": "rev-stimulatory"}, {"source": "ENSG00000104432", "type": "stimulatory", "target": "ENSG00000147168"}, {"source": "ENSG00000109471", "type": "stimulatory", "target": "ENSG00000134460", "reverse": "rev-inhibitory"}, {"source": "ENSG00000109471", "type": "dual", "target": "ENSG00000147168", "reverse": "rev-inhibitory"}, {"source": "ENSG00000113520", "type": "stimulatory", "target": "ENSG00000147168", "reverse": "rev-directed"}, {"source": "ENSG00000134460", "type": "inhibitory", "target": "ENSG00000147168", "reverse": "rev-directed"}, {"source": "ENSG00000138684", "type": "stimulatory", "target": "ENSG00000147168"}, {"source": "ENSG00000147168", "target": "ENSG00000164136", "reverse": "rev-stimulatory"}], "drugs": [{"indications": [{"efo_term": "METASTATIC MELANOMA", "stage": 4}, {"efo_term": "MELANOMA", "stage": 4}, {"efo_term": "CUTANEOUS MELANOMA", "stage": 4}, {"efo_term": "LEUKEMIA", "stage": 3}, {"efo_term": "HIV INFECTION", "stage": 3}, {"efo_term": "RENAL CARCINOMA", "stage": 2}, {"efo_term": "ACUTE MYELOID LEUKEMIA", "stage": 2}, {"efo_term": "RENAL CELL CARCINOMA", "stage": 2}, {"efo_term": "AMYOTROPHIC LATERAL SCLEROSIS", "stage": 2}, {"efo_term": "BREAST CARCINOMA", "stage": 2}, {"efo_term": "CLEAR CELL RENAL CARCINOMA", "stage": 2}, {"efo_term": "ACUTE GRAFT VS. HOST DISEASE", "stage": 2}, {"efo_term": "LIVER DISEASE", "stage": 2}, {"efo_term": "TYPE I DIABETES MELLITUS", "stage": 1}, {"efo_term": "ULCERATIVE COLITIS", "stage": 1}, {"efo_term": "CANCER", "stage": 1}, {"efo_term": "NEOPLASM", "stage": 1}, {"efo_term": "NEUROBLASTOMA", "stage": 1}, {"efo_term": "NEPHROTIC SYNDROME", "stage": 1}, {"efo_term": "ALOPECIA AREATA", "stage": 1}], "max_phase": 4, "name": "HUMAN INTERLEUKIN-2", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201438", "mechanisms": ["Interleukin-2 receptor agonist"], "genes": ["IL2RB", "IL2RA", "IL2RG"], "type": "Protein", "diseases": ["LEUKEMIA", "METASTATIC MELANOMA", "RENAL CARCINOMA", "TYPE I DIABETES MELLITUS", "ULCERATIVE COLITIS", "ACUTE MYELOID LEUKEMIA", "CANCER", "HIV INFECTION", "RENAL CELL CARCINOMA", "AMYOTROPHIC LATERAL SCLEROSIS", "NEOPLASM", "MELANOMA", "CUTANEOUS MELANOMA", "NEUROBLASTOMA", "BREAST CARCINOMA", "CLEAR CELL RENAL CARCINOMA", "NEPHROTIC SYNDROME", "ACUTE GRAFT VS. HOST DISEASE", "LIVER DISEASE", "ALOPECIA AREATA"]}, {"indications": [{"efo_term": "NEOPLASM", "stage": 4}, {"efo_term": "MELANOMA", "stage": 2}, {"efo_term": "OVARIAN CARCINOMA", "stage": 2}, {"efo_term": "PANCREATIC CARCINOMA", "stage": 2}, {"efo_term": "LYMPHOMA", "stage": 2}, {"efo_term": "T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA", "stage": 2}, {"efo_term": "ACUTE GRAFT VS. HOST DISEASE", "stage": 2}, {"efo_term": "MULTIPLE MYELOMA", "stage": 1}, {"efo_term": "MALE BREAST CARCINOMA", "stage": 1}, {"efo_term": "UNSPECIFIED PERIPHERAL T-CELL LYMPHOMA", "stage": 1}], "max_phase": 4, "name": "DENILEUKIN DIFTITOX", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201550", "mechanisms": ["Interleukin-2 receptor binding agent"], "genes": ["IL2RB", "IL2RA", "IL2RG"], "type": "Protein", "diseases": ["MULTIPLE MYELOMA", "MELANOMA", "OVARIAN CARCINOMA", "PANCREATIC CARCINOMA", "NEOPLASM", "MALE BREAST CARCINOMA", "LYMPHOMA", "T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA", "ACUTE GRAFT VS. HOST DISEASE", "UNSPECIFIED PERIPHERAL T-CELL LYMPHOMA"]}, {"indications": [{"efo_term": "IMMUNE SYSTEM DISEASE", "stage": 4}, {"efo_term": "ISCHEMIA REPERFUSION INJURY", "stage": 3}, {"efo_term": "ULCERATIVE COLITIS", "stage": 2}, {"efo_term": "CHRONIC KIDNEY DISEASE", "stage": 2}, {"efo_term": "ACUTE GRAFT VS. HOST DISEASE", "stage": 2}, {"efo_term": "UVEITIS", "stage": 2}, {"efo_term": "NEOPLASM", "stage": 1}, {"efo_term": "ACUTE MYELOID LEUKEMIA", "stage": 1}], "max_phase": 4, "name": "BASILIXIMAB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201439", "mechanisms": ["Interleukin-2 receptor inhibitor"], "genes": ["IL2RB", "IL2RA", "IL2RG"], "type": "Antibody", "diseases": ["NEOPLASM", "ULCERATIVE COLITIS", "IMMUNE SYSTEM DISEASE", "CHRONIC KIDNEY DISEASE", "ACUTE GRAFT VS. HOST DISEASE", "ISCHEMIA REPERFUSION INJURY", "ACUTE MYELOID LEUKEMIA", "UVEITIS"]}, {"indications": [{"efo_term": "IMMUNE SYSTEM DISEASE", "stage": 4}, {"efo_term": "RELAPSING-REMITTING MULTIPLE SCLEROSIS", "stage": 4}, {"efo_term": "MULTIPLE SCLEROSIS", "stage": 3}, {"efo_term": "PSORIASIS", "stage": 1}], "max_phase": 4, "name": "DACLIZUMAB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201605", "mechanisms": ["Interleukin-2 receptor inhibitor"], "genes": ["IL2RB", "IL2RA", "IL2RG"], "type": "Antibody", "diseases": ["PSORIASIS", "IMMUNE SYSTEM DISEASE", "RELAPSING-REMITTING MULTIPLE SCLEROSIS", "MULTIPLE SCLEROSIS"]}, {"indications": [{"efo_term": "LEUKEMIA", "stage": 2}, {"efo_term": "LYMPHOMA", "stage": 2}], "max_phase": 2, "name": "LMB-2", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2109367", "mechanisms": ["Interleukin-2 receptor alpha chain binding agent"], "genes": ["IL2RA"], "type": "Antibody", "diseases": ["LEUKEMIA", "LYMPHOMA"]}, {"indications": [{"efo_term": "PSORIASIS", "stage": 2}, {"efo_term": "CELIAC DISEASE", "stage": 2}], "max_phase": 2, "name": "AMG-714", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2109467", "mechanisms": ["Interleukin-15 inhibitor"], "genes": ["IL15"], "type": "Antibody", "diseases": ["PSORIASIS", "CELIAC DISEASE"]}, {"indications": [{"efo_term": "TUBERCULOSIS", "stage": 2}], "max_phase": 2, "name": "PASCOLIZUMAB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2108119", "mechanisms": ["Interleukin-4 inhibitor"], "genes": ["IL4"], "type": "Antibody", "diseases": ["TUBERCULOSIS"]}, {"indications": [], "max_phase": 2, "name": "INOLIMOMAB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2108370", "mechanisms": ["Interleukin-2 receptor alpha chain antagonist"], "genes": ["IL2RA"], "type": "Antibody", "diseases": []}], "heat": 0.100822206956275, "nodes": [{"assoc": 0.2, "id": "ENSG00000100385", "label": "IL2RB"}, {"assoc": 0.02786, "id": "ENSG00000104432", "label": "IL7"}, {"assoc": 0.0489776556502, "id": "ENSG00000109471", "label": "IL2"}, {"assoc": 0.019621, "id": "ENSG00000113520", "label": "IL4"}, {"assoc": 0.2, "id": "ENSG00000134460", "label": "IL2RA"}, {"assoc": 0.073304, "id": "ENSG00000138684", "label": "IL21"}, {"assoc": 0.2, "id": "ENSG00000147168", "label": "IL2RG"}, {"assoc": 0.036815, "id": "ENSG00000164136", "label": "IL15"}], "size": 8}, {"diseases": ["TYPE I DIABETES MELLITUS", "OBESITY", "NON-ALCOHOLIC FATTY LIVER DISEASE", "LIPODYSTROPHY", "RHEUMATOID ARTHRITIS", "CROHN'S DISEASE", "IMMUNE SYSTEM DISEASE", "MULTIPLE MYELOMA", "MYELODYSPLASTIC SYNDROME", "GIANT LYMPH NODE HYPERPLASIA", "PROSTATE CARCINOMA", "RENAL CARCINOMA", "RENAL CELL CARCINOMA", "SCHIZOPHRENIA", "UNIPOLAR DEPRESSION", "ASTHMA", "PSORIATIC ARTHRITIS", "ACUTE GRAFT VS. HOST DISEASE", "SYSTEMIC LUPUS ERYTHEMATOSUS"], "links": [{"source": "ENSG00000116678", "type": "stimulatory", "target": "ENSG00000138378"}, {"source": "ENSG00000116678", "type": "directed", "target": "ENSG00000174697", "reverse": "rev-stimulatory"}, {"source": "ENSG00000132693", "type": "stimulatory", "target": "ENSG00000136244", "reverse": "rev-stimulatory"}, {"source": "ENSG00000132693", "target": "ENSG00000174697", "reverse": "rev-stimulatory"}], "drugs": [{"indications": [{"efo_term": "IMMUNE SYSTEM DISEASE", "stage": 4}, {"efo_term": "GIANT LYMPH NODE HYPERPLASIA", "stage": 4}, {"efo_term": "MULTIPLE MYELOMA", "stage": 2}, {"efo_term": "MYELODYSPLASTIC SYNDROME", "stage": 2}, {"efo_term": "PROSTATE CARCINOMA", "stage": 2}, {"efo_term": "RENAL CARCINOMA", "stage": 2}, {"efo_term": "RENAL CELL CARCINOMA", "stage": 2}, {"efo_term": "SCHIZOPHRENIA", "stage": 1}, {"efo_term": "TYPE I DIABETES MELLITUS", "stage": 0}], "max_phase": 4, "name": "SILTUXIMAB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1743070", "mechanisms": ["Interleukin-6 inhibitor"], "genes": ["IL6"], "type": "Antibody", "diseases": ["IMMUNE SYSTEM DISEASE", "MULTIPLE MYELOMA", "MYELODYSPLASTIC SYNDROME", "TYPE I DIABETES MELLITUS", "GIANT LYMPH NODE HYPERPLASIA", "PROSTATE CARCINOMA", "RENAL CARCINOMA", "RENAL CELL CARCINOMA", "SCHIZOPHRENIA"]}, {"indications": [{"efo_term": "LIPODYSTROPHY", "stage": 4}, {"efo_term": "OBESITY", "stage": 3}, {"efo_term": "NON-ALCOHOLIC FATTY LIVER DISEASE", "stage": 2}, {"efo_term": "TYPE I DIABETES MELLITUS", "stage": 1}], "max_phase": 4, "name": "METRELEPTIN", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2107857", "mechanisms": ["Leptin receptor agonist"], "genes": ["LEPR"], "type": "Protein", "diseases": ["TYPE I DIABETES MELLITUS", "OBESITY", "NON-ALCOHOLIC FATTY LIVER DISEASE", "LIPODYSTROPHY"]}, {"indications": [{"efo_term": "RHEUMATOID ARTHRITIS", "stage": 2}, {"efo_term": "CROHN'S DISEASE", "stage": 2}, {"efo_term": "PSORIATIC ARTHRITIS", "stage": 2}, {"efo_term": "ACUTE GRAFT VS. HOST DISEASE", "stage": 1}], "max_phase": 2, "name": "CLAZAKIZUMAB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2108589", "mechanisms": ["Interleukin-6 inhibitor"], "genes": ["IL6"], "type": "Antibody", "diseases": ["RHEUMATOID ARTHRITIS", "CROHN'S DISEASE", "PSORIATIC ARTHRITIS", "ACUTE GRAFT VS. HOST DISEASE"]}, {"indications": [{"efo_term": "RHEUMATOID ARTHRITIS", "stage": 3}, {"efo_term": "UNIPOLAR DEPRESSION", "stage": 2}, {"efo_term": "ASTHMA", "stage": 2}], "max_phase": 3, "name": "SIRUKUMAB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1743071", "mechanisms": ["Interleukin-6 inhibitor"], "genes": ["IL6"], "type": "Antibody", "diseases": ["RHEUMATOID ARTHRITIS", "UNIPOLAR DEPRESSION", "ASTHMA"]}, {"indications": [{"efo_term": "RHEUMATOID ARTHRITIS", "stage": 3}, {"efo_term": "CROHN'S DISEASE", "stage": 2}], "max_phase": 3, "name": "OLOKIZUMAB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1743050", "mechanisms": ["Interleukin-6 inhibitor"], "genes": ["IL6"], "type": "Antibody", "diseases": ["RHEUMATOID ARTHRITIS", "CROHN'S DISEASE"]}, {"indications": [{"efo_term": "SYSTEMIC LUPUS ERYTHEMATOSUS", "stage": 2}, {"efo_term": "CROHN'S DISEASE", "stage": 2}], "max_phase": 2, "name": "PF-04236921", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2109613", "mechanisms": ["Interleukin-6 inhibitor"], "genes": ["IL6"], "type": "Antibody", "diseases": ["SYSTEMIC LUPUS ERYTHEMATOSUS", "CROHN'S DISEASE"]}, {"indications": [], "max_phase": 2, "name": "ELSILIMOMAB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2108591", "mechanisms": ["Interleukin-6 inhibitor"], "genes": ["IL6"], "type": "Antibody", "diseases": []}], "heat": 0.03312519777778, "nodes": [{"assoc": 0.030096, "id": "ENSG00000116678", "label": "LEPR"}, {"assoc": 0.0525535833333, "id": "ENSG00000132693", "label": "CRP"}, {"assoc": 0.0525564055556, "id": "ENSG00000136244", "label": "IL6"}, {"assoc": 0.015054, "id": "ENSG00000138378", "label": "STAT4"}, {"assoc": 0.015366, "id": "ENSG00000174697", "label": "LEP"}], "size": 5}, {"diseases": [], "links": [{"source": "ENSG00000102970", "type": "directed", "target": "ENSG00000162692", "reverse": "rev-directed"}, {"source": "ENSG00000102970", "type": "stimulatory", "target": "ENSG00000183813", "reverse": "rev-directed"}, {"source": "ENSG00000126353", "type": "manual", "target": "ENSG00000102962"}, {"source": "ENSG00000102962", "type": "manual", "target": "ENSG00000183813"}], "drugs": [], "heat": 0.0305910374195, "nodes": [{"assoc": 0.010746, "id": "ENSG00000102970", "label": "CCL17"}, {"assoc": 0.024444, "id": "ENSG00000126353", "label": "CCR7"}, {"assoc": 0.0413011870975, "id": "ENSG00000162692", "label": "VCAM1"}, {"assoc": 0.076464, "id": "ENSG00000183813", "label": "CCR4"}, {"assoc": 0, "id": "ENSG00000102962", "label": "CCL22"}], "size": 5}, {"diseases": ["ACUTE LYMPHOBLASTIC LEUKEMIA", "LEUKEMIA", "LYMPHOMA", "B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA", "NEOPLASM", "CHRONIC LYMPHOCYTIC LEUKEMIA", "DIFFUSE LARGE B-CELL LYMPHOMA", "NON-HODGKINS LYMPHOMA", "SYSTEMIC SCLERODERMA", "NEUROMYELITIS OPTICA", "MULTIPLE SCLEROSIS", "CANCER", "LYMPHOID NEOPLASM"], "links": [{"source": "ENSG00000012124", "target": "ENSG00000177455"}, {"source": "ENSG00000177455", "target": "ENSG00000197943", "reverse": "rev-directed"}], "drugs": [{"indications": [{"efo_term": "ACUTE LYMPHOBLASTIC LEUKEMIA", "stage": 4}, {"efo_term": "NEOPLASM", "stage": 4}, {"efo_term": "ACUTE LYMPHOBLASTIC LEUKEMIA", "stage": 3}, {"efo_term": "B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA", "stage": 2}, {"efo_term": "DIFFUSE LARGE B-CELL LYMPHOMA", "stage": 2}, {"efo_term": "NON-HODGKINS LYMPHOMA", "stage": 2}, {"efo_term": "CHRONIC LYMPHOCYTIC LEUKEMIA", "stage": 1}], "max_phase": 4, "name": "BLINATUMOMAB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1742992", "mechanisms": ["B-lymphocyte antigen CD19 cross-linking agent"], "genes": ["CD19"], "type": "Antibody", "diseases": ["ACUTE LYMPHOBLASTIC LEUKEMIA", "B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA", "CHRONIC LYMPHOCYTIC LEUKEMIA", "DIFFUSE LARGE B-CELL LYMPHOMA", "NON-HODGKINS LYMPHOMA", "NEOPLASM"]}, {"indications": [{"efo_term": "NEUROMYELITIS OPTICA", "stage": 2}, {"efo_term": "SYSTEMIC SCLERODERMA", "stage": 1}, {"efo_term": "MULTIPLE SCLEROSIS", "stage": 1}, {"efo_term": "CANCER", "stage": 1}, {"efo_term": "LYMPHOID NEOPLASM", "stage": 1}], "max_phase": 2, "name": "MEDI-551", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2109334", "mechanisms": ["B-lymphocyte antigen CD19 other"], "genes": ["CD19"], "type": "Antibody", "diseases": ["SYSTEMIC SCLERODERMA", "NEUROMYELITIS OPTICA", "MULTIPLE SCLEROSIS", "CANCER", "LYMPHOID NEOPLASM"]}, {"indications": [{"efo_term": "ACUTE LYMPHOBLASTIC LEUKEMIA", "stage": 2}, {"efo_term": "B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA", "stage": 2}, {"efo_term": "LEUKEMIA", "stage": 1}, {"efo_term": "LYMPHOMA", "stage": 1}], "max_phase": 3, "name": "MOXETUMOMAB PASUDOTOX", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1743043", "mechanisms": ["CD22 other"], "genes": ["CD22"], "type": "Antibody", "diseases": ["ACUTE LYMPHOBLASTIC LEUKEMIA", "LEUKEMIA", "LYMPHOMA", "B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA"]}, {"indications": [{"efo_term": "NEOPLASM", "stage": 4}, {"efo_term": "ACUTE LYMPHOBLASTIC LEUKEMIA", "stage": 3}, {"efo_term": "LYMPHOMA", "stage": 2}], "max_phase": 3, "name": "INOTUZUMAB OZOGAMICIN", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2108611", "mechanisms": ["CD22 binding agent"], "genes": ["CD22"], "type": "Antibody", "diseases": ["ACUTE LYMPHOBLASTIC LEUKEMIA", "LYMPHOMA", "NEOPLASM"]}, {"indications": [{"efo_term": "ACUTE LYMPHOBLASTIC LEUKEMIA", "stage": 2}, {"efo_term": "DIFFUSE LARGE B-CELL LYMPHOMA", "stage": 2}], "max_phase": 2, "name": "SAR-3419", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2109286", "mechanisms": ["B-lymphocyte antigen CD19 binding agent"], "genes": ["CD19"], "type": "Antibody", "diseases": ["ACUTE LYMPHOBLASTIC LEUKEMIA", "DIFFUSE LARGE B-CELL LYMPHOMA"]}, {"indications": [{"efo_term": "LEUKEMIA", "stage": 2}], "max_phase": 2, "name": "CAT-3888", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2109352", "mechanisms": ["CD22 binding agent"], "genes": ["CD22"], "type": "Antibody", "diseases": ["LEUKEMIA"]}, {"indications": [], "max_phase": 3, "name": "BECTUMOMAB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2108228", "mechanisms": ["CD22 other"], "genes": ["CD22"], "type": "Antibody", "diseases": []}, {"indications": [], "max_phase": 1, "name": "TAPLITUMOMAB PAPTOX", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2107890", "mechanisms": ["B-lymphocyte antigen CD19 binding agent"], "genes": ["CD19"], "type": "Antibody", "diseases": []}, {"indications": [], "max_phase": 2, "name": "ONCOLYSIN B", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2109308", "mechanisms": ["B-lymphocyte antigen CD19 binding agent"], "genes": ["CD19"], "type": "Antibody", "diseases": []}], "heat": 0.0246435, "nodes": [{"assoc": 0.014184, "id": "ENSG00000012124", "label": "CD22"}, {"assoc": 0.0350705, "id": "ENSG00000177455", "label": "CD19"}, {"assoc": 0.024676, "id": "ENSG00000197943", "label": "PLCG2"}], "size": 3}, {"diseases": [], "links": [{"source": "ENSG00000100312", "type": "manual", "target": "ENSG00000188488"}, {"source": "ENSG00000188488", "type": "manual", "target": "ENSG00000115718"}, {"source": "ENSG00000115718", "type": "manual", "target": "ENSG00000101000"}, {"source": "ENSG00000178726", "type": "manual", "target": "ENSG00000115718"}], "drugs": [], "heat": 0.02392257177324, "nodes": [{"assoc": 0.0414897477551, "id": "ENSG00000100312", "label": "ACR"}, {"assoc": 0.032162, "id": "ENSG00000101000", "label": "PROCR"}, {"assoc": 0.0459611111111, "id": "ENSG00000178726", "label": "THBD"}, {"assoc": 0, "id": "ENSG00000188488", "label": "SERPINA5"}, {"assoc": 0, "id": "ENSG00000115718", "label": "PROC"}], "size": 5}], "auto_delta": "0.000172615"}